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Abstract 
The caterpil lar fungus Cordyceps militaris (CM) is a wel l -known tradi t ional 
Chinese medicine (TCM) which can be artif icially cult ivated in a large scale. In the 
recent decades, CM extract has been reported to exert di f ferent biological activities 
such as ant i - tumor, anti-oxidation, and immune-modulat ion. Like Cordyceps sinensis, 
the expensive wi ld f ru i t ing form of Cordyceps, CM has been used to t reat respiratory 
diseases. In addit ion, the water extract of CM has a higher amount of cordycepin 
than other Cordyceps species. This pure compound has been found to have 
mult i-biological funct ions as wel l , like antMlmgal , ant卜viral and anti-aggregation. 
In this study, 16HBE14o-, a human bronchial epithel ial cell line, was used as a 
model to study the regulation of ion t ransport by CM water extract and cordycepin. 
16HBE140- epithelia were grown on Transwell-COL membranes unti l conf luent. 
Monolayers were mounted in Ussing chambers and the increase in short-circuit 
current (Uc； an index of electrogenic ion transport) was measured by 
electrophysiological technique. The apical or basolateral application of CM extract 
and cordycepin could stimulate an Isc response in a dose-dependent manner. The \sc 
responses could be inhibited by apical application of cystic fibrosis t rans-membrane 
conductance regulator (CFTR) channel blocker, CFTR—m, and calcium-activated CI" 
channel (CaCC) blocker, DIDS. The Uc responses were sensitive to basolateral 
application of Chromanol 293B, a cAMP-dependent K+ channel blocker and TRAM-34, 
an intermediate-conductance Ca^.-activated K+ channel blocker. Although cordycepin 
could only induce a minimal Increase in basolateral K+ current in 
nystatin-permeabilized epithelia, similar inhibitory patterns were obtained in 
epithelia st imulated w i th CM extract or cordycepin. Both CM- and 
XV 
cordycepin- induced Isc could be inhibi ted by adenylate cyclase (AC) inhib i tor 
MDL-12330A, protein kinase A (PKA) inhib i tor H89, and intracellular Ca^^ chelator 
BAPTA-AM. The data f rom PKA assay suggested tha t CM extract and cordycepin 
caused a significant increase in PKA act iv i ty compared w i th untreated control 
epithel ia. Furthermore, the data obta ined f rom microf luor imetr ic measurement 
revealed cordycepin was able to increase intracellular Ca^^ concentrat ions in 
16HBE140-cel ls. 
In summary, both cordycepin and CM extract st imulated CI' secretion across 
human bronchial epithel ia, possibly via apical CFTR, CaCC and the basolateral K+ 
channels are involved in dr iv ing apical CI" exit. The under ly ing signal t ransduct ion 
mechanisms involve both AC/cAMP/PKA and Ca^^-dependent pathways. However, 
the effect o f CM extract was part ly mediated by cordycepin, wh ich might not be the 
main active ingredient to evoke Uc responses. The Uc responses st imulated by CM 
extract might come f rom other active Ingredients present in the extract in addi t ion to 
cordycepin. The results can expand our knowledge about the biological funct ions of 
this t radi t ional herbal medicine and provide a mechanist ic explanation for Its 
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Chapter 1 Introduction 
1.1 Genus Cordyceps 
Cordyceps is one o f the genuses in the fungi fami ly Clavicipitaceae. There are 
more than 400 species of Cordyceps occurr ing in the wi ld. They can be found in all 
cont inents around the wor ld (Das et al” 2010; Sung et o/., 2007). 
Like other members in Clavicipitaceae, species in the genus Cordyceps are able 
to produce cylindrical and thickened asci for reproduct ion (Sung et al., 2007). On the 
o ther hand, Cordyceps species feed themselves by parasitism. Some of the Cordyceps 
species are able to control the hosts' behaviour so as to increase thei r f i tness to 
survival. For example, the worker ants infected w i t h Cordyceps unilateralis wi l l gr ip 
the leaves or branches of plants before they are killed by the fungus (Hughes et al., 
2011) (Fig. 1.1.1). The mycel ium invades the body o f the host for nut r i t ion and 
produce toxins to cause their death. The mummi f ica t ion process takes t ime tha t it 
may last for several months. At the end, f ru i t ing bodies grow f rom the hosts' dead 
bodies and produce spores for reproduct ion (Paterson, 2008.). The spore-containing 
f ru i t bodies wi l l be discharged as f i laments when they become mature (Shrestha et 
al., 2005). 
Cordyceps species mainly invade insects or o ther ar thropods as thei r hosts. 
Most of the Cordyceps species can only invade a specific host species (e . g . Cordyceps 
sinensis), whi le the others can invade a group of related host species (e . g . Cordyceps 
militaris) (Paterson, 2008.). At the same t ime, Cordyceps produce a large variety o f 
biochemical compounds w i th medicinal funct ions. Thus, some East Asian countr ies 
have been using Cordyceps as natural herbal drugs for a long history period o f t ime, 
which is several centuaries earl ier than Western countries. Since it is tough in texture, 
1 
t radi t ional ly people consume Cordyceps by making t h e m into herbal soup w i t h meat. 
Due to the advance in biotechnology, Cordyceps are made into capsules to preserve 
active Ingredients inside the crude extract. 
The earl iest documenta t ion o f using Cordyceps as herbal medicine is come f r om 
a Tibet ian physician in the 15出 centuaries (Das et al., 2010). Not only Cordyceps 
sinensis and Cordcyeps militaris, there are more and more Cordyceps species 
repor ted to have medicinal funct ions. For example, the extract o f Cordyceps pruinoso 
can induce apoptosis in human cervical cancer cell line He La (Kim et al., 2010). In the 
2ist ceuntry, there are increasing demands o f natural products for dietary 
supplements. This arouses the awareness o f safety about consumpt ions of heral 
medicines. Therefore, in the recent decades, scientists have conducted a lot o f 
research projects to characterize the active ingredients and medicinal funct ions o f 
these natural products. 
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Fig. 1.1.1 - A dead ant infected by Cordyceps species. Not ice tha t the f ru i t ing bodies 
o f Cordyceps g rown f r om the ant 's dead body. (Adapted f r o m Wik ipedia -
"Cordyceps") 
3 
1.2 Cordyceps militaris 
Cordyceps militaris (CM) is one o f the impor tant medicinal caterpi l lar fungi in 
t rad i t ional Chinese medicine (TCM). CM is abundant since it can be found at most of 
the places in China. In the wi ld , CM invades the pupae or larvae o f a range o f 
lepidoptero species (like butterf l ies and moths) under the ground. Their mycelia g row 
in the host's gut and produces toxins tha t can kill the hosts. One or few cylindrical 
f ru i t ing bodies emerge f r om the hosts' dead bodies and grow above the soil (Das et 
o/., 2010; Paterson, 2008). The spore-containing bodies wi l l be discharged as 
f i laments when they are mature. W h e n there is a suitable env i ronment w i th 
favourable humid i ty and temperature, they wi l l germinate w i th in 36 hours (Shrestha 
et al., 2005). 
In the recent decades, scientists have successfully t r ied to cult ivate CM in a large 
scale so tha t the cost o f product ion can be lower. It is because Cordyceps sinensis, 
the expensive and wi ld f ru i t ing Cordyceps species, can only be found in grasslands 
and shrublands around Tibetan Plateau, which is 3000 m above the sea level (Fig. 
1.2.1 and 1.2.2). Due to the scarce supply and over-exploi tat ion o f the env i ronment , 
f r om 1980s to 2006, the price o f Cordyceps sinensis has Increased about 20 t imes 
(Winkler, 2008). In order t o increase the weight o f collected Cordyceps sinensis, some 
bad collectors may insert iron or lead wires into the f ru i t ing bodies for prof i t . The 
adul terated products may lead to harmful health effects such as heavy metal 
poisoning (Holliday et a!., 2005). Thus CM has become an impor tant subst i tute of 
Cordyceps sinensis as herbal medicine (Fig. 1.2.3). 
Some of the common methods used in art i f icial cul t ivat ion are shaking culture, 
submerged culture and surface liquid culture. In shaking and submerged culture, the 
inoculums of Cordyceps militaris are grown in bioreactors to raise the yield. On the 
o ther hand, in surface l iquid culture, the inoculum is grown on the surface o f l iquid 
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mecMum inside a sterile glass bott le. Among all o f them, the surface l iquid cul ture can 
give the highest yield o f CM biomass (Das et al, 2008; Hung et al, 2009). The 
scientists can fu r ther p romote the yield by opt imizat ion o f culture media as we l l as 
generat ion o f highly-product ive mutan t strains by pro ton beam irradiations (Masuda 
et al., 2011). 
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l i f 
Fig. 1.2.1 - Cordyceps sinensis used in traditional Chinese medicine (TCM) (Adapted 
f r om websi te "drp jnna.com") . 
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Fig. 1.2.2 - Natural distribution of Cordyceps sinensis (shown as shaded region) in 
the Western part of China (Adapted f r om Winkler, 2008.). 
7 
Fig. 1.2.3 - Cordyceps militaris found in the wild (Adapted f r o m websi te 
" t reknature .com") . 
8 
1.3 Biological Functions and Chemical Constituents of Cordyceps 
militaris 
As ment ioned before, in many East Asian countries, Cordyceps species have 
been used as herbal medicine for a long period of t ime. One o f the examples is 
Cordyceps sinensis. The f irst record about the medicinal uses of Cordyceps sinensis 
has been wr i t ten In the book "Ben Cao Bei Yao" in Qing Dynasty (c. 1694). According 
to this historical record, Cordyceps sinensis was claimed to be beneficial to lung and 
kidney funct ions. In modern medical studies, the extracts of Cordyceps were found to 
exert a wide range of biological funct ions, such as ant卜depressant (Nishizawa et ai, 
2007), ant i -oxidant (Yamaguchi et al., 2000), ant i - tumor (Zhang et ai, 2005), 
anti-aging (Ji et al., 2009), immuno-modula t ion (Jordan et al； 2008), lower blood 
cholesterol level (Koh et al., 2003) and st imulat ion of normal cell repair (Marchbank 
et ai, 2011), etc. 
In t radi t ional Chinese Medicine, both Cordyceps sinensis and Cordyceps militaris 
were able to t reat pulmonary diseases, such as asthma, chronic bronchit is and 
chronic obstruct ive pulmonary diseases (Gai et o/., 2004; Sun et al., 1997). However, 
the intracellular signal t ransduct ion behind the pharmacological responses has not 
been wel l studied yet. Also, it was not clear which pure compounds were responsible 
for regulating ion t ranspor t in epithel ial cells dur ing mucus clearance. Al though the 
previous project in our laboratory used Calu-3 as the model cell line to demonstrate 
the effects of these t w o Cordyceps extracts (Yue et al., 2008), Calu-3 cells showed the 
features more similar to serous cells In trachea-bronchial glands than surface 
epithelia (Shan et al., 2011). Therefore, 16HBE14o- cells were used to investigate the 
trans-epithel ial C「 transport across human airway. 16HBE14o- was an immortal ized 
cell line derived f rom normal human bronchial surface epithelia (Cozens et al., 1994； 
Gruenert et al., 1988). The morphology of 16HBE14o- cells was similar to that o f the 
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normal epi thel ia l cells, such as microvi l l i and cilia (Gruenert et al., 1995). Moreover, 
various ion channels and t ransporters were expressed on cell surface for 
investigation of d rug metabol ism and ion t ranspor t (Ricciardolo et al., 1998; Tousson 
et a!., 1998; Wine e ta / . , 1994). 
CM extract contains d i f ferent kinds o f biochemical compounds and molecules, 
such as vi tamins, amino acids and lipids (ergosterol) (Ng et al., 2005). Scientists could 
isolate some pure funct ional proteins or peptides. For example, it was found that 
trypsin-l ike proteases in the extract worked better In the alkaline env i ronment 
(Hattor i et al., 2005). The f ibr inolyt ic enzymes isolated f rom CM crude extract could 
cleave the insoluble f ibr in into soluble degraded products, so tha t the blood clots 
could be removed (Choi et al., 2011). An ant i fungal pept ide called cordymin was able 
to inhibi t the g row th of Candida albicans (Wong et al., 2011). Also, water-soluble 
polysaccharides could be ident i f ied as wel l , and some o f t hem may have ant i -oxidant 
activit ies in scavenging hydroxyl free radicals inside the cells (Yu et ai, 2007). 
Using high-performance l iquid chromatography (HPLC) technique, it was found 
tha t CM extract contained di f ferent nucleosides, for example, adenosine, guanosine, 
ur idine, inosine and cordycepin (Yuan et al., 2008). Among all sorts o f nucleosides 
found In CM extract, cordycepin (3'-deoxyadenoslne) is one of the most impor tan t 
compounds (Fig. 1.3.1). Our previous research found that the amount o f cordycepin 
was high in CM but nil in Cordyceps sinensis extract (Yue et al., 2008). As the 
molecular structure of cordycepin was similar to tha t o f adenosine, cordycepin was 
usually acted as a compet i t ive inhibi tor of adenosine in mRNA synthesis. The 
elongat ion of mRNA strand wou ld be terminated when cordycepin molecule 
incorporated into it (Siev et al., 1969). Furthermore, cordycepin prevented bladder 
cancer cells f r om invasion and migrat ion to o ther body tissues. Therefore, cordycepin 
was one o f potent ia l agents for t reat ing cancers (Lee et al., 2010). 
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o t h e r than an t i - tumor activity, cordycepin was able to per form ant i- fungal 
activit ies (Sugar et al., 1998). W h e n the mice were infected w i t h fungi, the survival 
rate was higher if the mice were t reated w i t h cordycepin for 10 days. Also, there 
were fewer fungal colonies g rown in the i r kidney samples. Futhermore, cordycepin 
was found to be anti-viral tha t it could reduce the act iv i ty of reverse transcriptase of 
human immunodef ic iency virus (HIV). This could faci l i tate to slow d o w n the 
repl icat ion of retroviruses (Monte f lo r i et al., 1989). Cordycepin was able to slow 
down the aggregation rate o f platelets as it could lower the product ion o f 
thromboxane, a pro-aggregating agent (Cho et al., 2007). Finally, it was 
immuno-modu la to ry tha t it could reduce the releases o f pro- in f lammatory cytokines 
f r om microglial cells in th r brain (Jeong et al., 2010). 
Since cordycepin was a mul t i - funct ional b iomolecule, we would also like to 
know whe the r this compound could affect ion t ranspor t across human airway 
epithel ia th rough certain intracellular pathways. 
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Fig. 1.3.1 - Molecular structure of cordycepin (3'-deoxyadenosine) (Adapted f r om 
W i k i p e d i a - " C o r d y c e p i n " ) . 
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1.4 Human Bronchial Epithelial Cell Line, 16HBE14o-
The respiratory system provides surface area for eff icient gaseous exchange. As 
there are direct interactions between cell surface and external environment, 
epithelial cells have an important role to play in regulating trans-cellular t ransport as 
wel l as protect ion against foreign agents such as toxic particles and pathogens. The 
apical side of bronchial epithelial cells secrets a liquid layer on the cell surface, which 
is known as "airway surface l iquid" (ASL). The ASL is made of two components - the 
mucus and watery layer (also known as "pericil iary l iquid, PCL") (Boucher, 1999). The 
ionic content of ASL is t ight ly control led by regulation of t ransport across the 
epithelia so as to minimize the resistance against inspiratory air f low (Ballard et a!., 
1999). Through the beating mot ions given by cilia, ASL moves along the epithelial 
surface for clearance of foreign agents (Matsui et oL, 1998). Also, the water in PCL 
can compensate the loss of water during venti lat ion. 
For research purposes, choosing a suitable cell model is essential for in vitro 
study of ion t ransport across bronchial epithelial cells. It is because a suitable cell 
model can provide useful informat ion about intracellular signal transduction and ion 
movement under simplif ied and well-control led experimental condit ions. The results 
would be more reproducible and consistent if the cell model can be immortal ized 
(Forbes, 2000). 
In the beginning of the 1990s, 16HBE14o- cell line was developed to study drug 
transport across human airway epithelia (Forbes et oL, 2003). It was developed 
originally f rom surface bronchial epithelial cells in a one-year old male 
organ-transplant patient. The cells were immortal ized by transfection of pSVori' 
plasmid (Cozens et al., 1994). This plasmid contained a Simian Virus 40 (SV40) 
genome, so that it encodes the Large T-antigen to suppress the actions of 
tumor-suppressing p53 gene (Marano et a I., 2002). 
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16HBE14o- cell line is similar with the normal bronchial epithelial cells. They can 
form polarized monolayer above collagen-coated permeable support (Ehrhardt et al., 
2002) (Fig. 1.4.1). The presence of intracellular junction proteins (such as ZO-l and 
PSD-95) and well-organized actin filaments suggest that 16HBE14o- cells are linked 
together by different types of cell-cell adhesion, such as tight junction, gap junction 
and adherens junction (Nilsson et al., 2010). The apical side of 16HBE14o- is 
specialized with the formation of finger-like microvilli and cilia. Moreover, some 
important ion channels and transport proteins are expressed on the cell surface for 
regulated ion transport as well as intracellular signal transductions. For example, 
there are cystic fibrosis trans-membrane conductance regulator (CFTR) channels for 
cr and HC03- transport (Haws et al., 1992), P-glycoprotein (P-gp) for extrusion of 
drug molecules against concentration gradient, and caveolin for internalization of 
large molecules or particles (Ehrhardt et al., 2003). Thus, 16HBE14o- is a suitable 
model to study ion transport and drug metabolism in human bronchial epithelia. 
14 
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1.5 Ion Transport in Human Bronchial Epithelial Cells 
Regulations o f ion t ranspor t are impor tan t In bronchial epi thel ial cells for 
effect ive funct ion, because the change in ionic composi t ions o f ASL may affect 
vo lume as wel l as viscosity of ASL along the airway. As discussed above, the 
16HBE140- cells are linked together w i th d i f ferent cell-cell adhesions. The presence 
o f t ight junct ions suggested that direct ional ion t ranspor t was present In epi thel ia l 
cells (Marano et al., 2002). It was because the t igh t junct ion proteins separate the 
cell surface membrane o f epi thel ia l cells Into t w o compar tments - the apical (facing 
towards the lumen) and basolateral side (facing towards the inner layer o f bronchial 
tissues). Therefore, the t w o separate membrane compar tments wou ld have d i f ferent 
composi t ions o f ion channels and t ranspor t proteins to effect ively control vector ial 
ion t ranspor t across the layer. 
The results f r o m the past research revealed that the addi t ion o f a m i lo ride, an 
epithel ial Na+ channel (ENaC) blocker, could not inhibi t short-circui t current response. 
This suggested tha t 16HBE14o- did not conduct Na+ current. It was believed tha t 
16HBE140- cells lost the expression of ENaC when they became immortal ized af ter 
the t ransformat ion process (Kunzelmann et al., 1996). Alternatively, the conductance 
of 16HBE140- should mainly come f rom CI secretion. It was because 16HBE14o- cells 
expressed a high level of CFTR mRNA and protein, which were comparable to T84, a 
colon epithel ial cancer cell line which was also a commonly used standard for 
studying CI" t ranspor t (Cozens et al” 1994). 
In normal airway epithel ia cells, CI" ions move into the cells across the 
basolateral membrane th rough Na+-K+-2C|- co-transporter NKCCl. The intracellular CI' 
ions are secreted f rom apical membrane through CFTR and Ca^.-activated Cf 
channels (CaCC). In addi t ion, K+ ions are recycled across basolateral membrane 
through t w o kinds of K+ channels, one is cAMP-activated (KvLQTl) and the other is 
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Ca2+-activated (KCNN4). These K+ channels provide driving force to facil i tate apical CI" 
secretions. 
Na+-K+-2C|- co-transporter NKCCl is a prote in w i t h 120 kDa in size. It is 
expressed basolaterally in most of the cells. The act iv i ty o f NKCCl is not af fected by 
the presence of CI", Na+, K+, Ca^"" or H+ concentrat ions in the cytosol. 
Depolymerizat ion o f actin f i laments in cytoskeleton activates NKCCl funct ion whi le 
the addi t ion of specific inhibitors (like bumetanide) reduces its activity. This is due to 
the balance of ion secretion and reabsorpt ion across the bronchial epithel ia (Dawson 
et al., 1990; Hannaert et al., 2002). 
CFTR is a cAMP-activated and phosphory lat ion-regulated CI" channel. It is 170 
kDa in size and 1480 amino acids in length. The CFTR protein had t w o 
membrane-spanning domains (as 丨on channel), t w o nucleot ide-binding domains 
(hydrolyze ATP to produce energy fo r t ransport ) and one regulatory domain 
(activated by phosphorylat ion o f prote in kinase A or ATP) (Sheppard et al., 1999). t 
Each membrane-spanning domain has six t ransmembrane helices across the plasma 
membrane. CFTR channels are mainly expressed on the apical membrane of 
epithel ial cells, a l though some scientists suggested that there were a few CFTR-like 
C|- channels found in basolateral membrane (Fischer et al., 2007). The funct ion of 
CFTR channels was to regulate the t ranspor t of CI" across epithel ial cells, since CI" was 
impor tant in control l ing the volume of ASL. Besides ion t ransport , it was found that 
CFTR channels interacted w i th some adhesion proteins and cytoskeleton. This may 
be related to maintainance o f cell structure in bronchial epithel ia (Nilsson et al., 
2010). 
However, cystic f ibrosis (CF), a common genetic disorder in Caucasian 
populat ions (about 1 in 2500 live births), has an impaired CI' t ranspor t in airway 
epithel ia and o ther secretory ducts (Cozens et al., 1992). Due to mutat ions in CFTR 
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gene, the muta ted CFTR channels fail to secrete CI' to the apical lumen (McAuley et 
al., 2000). There are more than 700 types of mutat ions in the CFTR gene. However, 
the most common one is delet ion of codon which encodes for a phenylanal ine at the 
posit ion 508. This mutat ion (A F508) accounts for about 70% of tota l mutat ions in 
CFTR (Schultz et al., 1999). W i t h impaired secretory funct ions, there wi l l be a net 
absorpt ion o f ions and water back to epithel ial cells, leading to loss of watery layer in 
PCL (Kunzelmann, 2001). Therefore, the secretions (e.g. ASL) may be too viscous tha t 
the epithel ia cannot carry ou t mucus clearance properly. Mucus accumulat ions 
encourage the g rowth of micro-organisms, wh ich tr iggers fu r ther release of 
pro- in f lammatory mediators f r om epithel ial and immune cells (Smith et al., 1996). 
Finally, serious inf lammat ions and obstruct ions in patient 's respiratory t ract can be 
lethal. 
Ca2+-activated CI" channels (CaCC) is group o f channels tha t al low large anions, 
especially CI" to pass through. Scientists do not know too much about this kind of 
channels before successful c loning of gene sequence in the recent decades. The 
CaCCs belong to a protein fami ly called TMEM16. This prote in fami ly has 10 
substypes, named TMEM16A to 16K. 
The TMEM16 channels express in most o f the cells inside the human body. 
However, not all the subtypes in TMEM16 fami ly are expressed in a part icular cell 
l ine. For example, in 16HBE14o- cells, there are only TMEM16A, 16F and 16H found 
on the cell surface. The most common substype is the TMEM16A, which is also called 
as Anoctamin-1. This protein consists of eight t ransmembrane domains. Like CFTR 
channels, TMEM16A fo rm clusters on the plasma membrane for eff ic ient t ransport . 
When intracellular Ca "^" concentrat ion is high, TMEM16 proteins wi l l be activated by 
phosphorylat ion f rom Protein Kinase C (PKC) or Ca^VCalmodul in-Dependent Kinase 
(CAMK). On the other hand, they are sensitive to non-specific CP channel blockers, 
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like DIDS (Kunzelmann et a I., 2009). 
K+ channels are Impor tant in mainta in membrane potent ia l and generat ion of 
dr iv ing force to facil i tate apical CI—secretions. Both cAMP-act ivated (KvLQTl) and 
Ca^^-activated (KCNN4) one are common ly expressed in epi thel ia l cells, cardiac 
muscles cells and neurones (Mal l et al., 2000). 
cAMP-act ivated K+ channel KvLQTl is encoded by KCNQl gene located at 
chromosome 11. This channel is voltage-sensit ive and inhibi ted by the presence 
specific blockers like Chromanol 293B. The protein structure o f KvLQTl is made up of 
six t ransmembrane domains. However, they have to fo rm a homote t ramer in order 
to construct a funct ional uni t for K+ t ranspor t . On the o ther hand, the interact ions 
w i t h o ther accessory protein subunits, such as minK and miRP, are able to regulate 
conductance o f KvLQTl for K+ to pass through (Melman et al., 2002). 
Ca^^-activated K+ channel is encoded by KCNN4 gene located at chromosome 19. 
It is a 50 kDa protein tha t found in erythrocytes, lymphocytes as wel l as epithel ia in 
secretory ducts and organs. According to the i r single channel conductance (in terms 
of picoSiemens, an index for measuring dr iv ing force of ion influx), the Ca^^-activated 
K+ channels can be classified into large- (> 100 pS), intermediate- (10 - 100 pS) and 
small-conductance (< 10 pS) channels. The channels expressed on the surface of 
16HBE140- cells are the intermediate one (16 pS). Thus KCNN4 channels are also 
called as IK channels. They can be activated at high levels o f cytosolic Ca〗. w i th 
calmoudin but inhibi ted by specific blocker TRAM-34 (Bardou e t al., 2009; Fanger et 
al., 1999). 
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1.6 Objectives of the Experiments 
The aim of this project is to study the regulat ion of ion t ranspor t in human 
bronchial epi thel ia l cell line, 16HBE14o-, by CM water extract. In addi t ion, the 
regulat ion o f signal t ransduct ion pathway was studied, such as cAMP- and 
Ca2+-dependent pathways, by CM water extract as wel l . As discussed above, CM 
contains greater amount o f cordycepin than o ther Cordyceps species. Thus, in the 
second part of this project, the effects of this pure compound on ion t ranspor t and 
signaling pathways in 16HBE14o- cells were examined. 
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Chapter 2 Materials and Methods 
2.1 Solutions and Chemicals 
The bicarbonate-buffered K-H solut ion contained (In m M ) NaCi, 117; NaHCOs, 
25; KCI, 4.7; MgCb, 1.2; KH2PO4, 1.2; CaCb, 2.5; and p-glucose 11; and maintained at 
pH 7.4 when bubbled w i t h 95% oxygen / 5% carbon dioxide at 37。C. For the 
preparat ion o f low CI" solut ion, NaCi, KCI, MgCb and KH2PO4 were Isosmotically 
replaced by Na-gluconate, K-gluconate, Ca-gluconate and MgS〇4 respectively. For CI" 
-free solut ion, NaCi and KCI were replaced by Na-gluconate and K-gluconate, whi le 
CaCb was replaced by 11 m M Ca-gluconate. The IX phosphate buffered saline (PBS) 
contained (in m M ) NaCl, 137; KCI, 2.7; NazHPOq, 8.1 and KH2PO4, 1.76; w i t h pH 
calibrated to 7.4. 
The cell permeant acetoxymethyl ester (AM) forms o f Fura-2, BAPTA and 
pluronic F127 were obtained f rom Molecular Probes (Eugene, OR, USA). Cordycepin 
(3,-deoxyadenosine), DIDS, H89, MDL-12330A and TRAM-34 were obta ined f rom 
Sigma-Aldrich (St. Louis, MO, USA). CFTR-inhi72 was obtained f rom Calbiochem (San 
Diego, CA, USA). Chromanol 293B and 1-EBIO were obtained f r om Tocrls (Bristol, UK). 
All o ther necessary chemical reagents were obtained f r om Sigma-Aldrich (St. 
Louis, MO, USA). For preparat ion o f chemical stocks, ATP and cordycepin were 
dissolved in disti l led water and o ther chemicals were dissolved in d imethy l 
sulphoxide (DMSO). 
2 1 
2.2 Preparation of Hot Water Cordyceps militaris Extract 
The CM extract was kindly supplied by Professor Fung Kwok-Pui f r om Inst i tute o f 
Chinese Medic ine, the Chinese University o f Hong Kong. The Cordyceps militaris 
samples were purchased f r o m the herbal medicine healers in the main land China. 
Those samples were collected in Northeastern part o f China. The voucher specimens 
have been deposi ted in Museum of the Inst i tute o f Chinese Medic ine, the Chinese 
University o f Hong Kong. The samples were authent icated using morphological 
characters by Professor Zhong-zhun Zhao of School o f Chinese Medic ine, Hong Kong 
Baptist University. 
The water extract ion o f CM was previously described (Yue et al., 2008), since 
boi l ing in water was a t radi t ional method to extract contents inside the medicine. 
The CM f ru i t ing bodies were dried in an oven (60°C) for 24 hours. The who le dried 
f ru i t ing bodies were extracted in boiled disti l led water by ref luxing tw ice for 2 hours. 
The hot water extract was centr i fuged at 1000 x g for 15 minutes in order t o remove 
insoluble debris. Af ter that , the extracts were freeze-dried in l iquid ni trogen (-196。C). 
Then CM extract powder was re-dissolved in disti l led water to make up the f inal 
concentrat ion as 100 m g / m l for fu ture use. 
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2.3 Culture of Cells 
16HBE140- cells were obtained f rom Dr. Dieter Gruener t f r om the California 
Pacific Medical Center, San Francisco, USA. The cells were maintained in M i n i m u m 
Essential Med ium w i th Eagle's salt supplemented w i th 10% (v/v) fetal calf serum, 1% 
(v/v) r g l u tam ine , 100 I .U/ml penici l l in and 100 pig/ml streptomycin. The plastic cell 
cul ture flasks were coated w i t h f ibronect in and collagen (BD Biosciences, Bedford, 
MA, USA). The cells were incubated in 95% humidi f ied atmosphere - 5% carbon 
dioxide at 37°C. The med ium inside the cul ture flasks was changed every 3 to 4 days. 
The cells were trypsinized and passed into new cul ture flasks every 7 days. For the 
measurements of Isc, cells were seeded on Transwell-COL membranes w i t h 0.4 \xm 
pore diameter. The surface area o f each membrane was 0.2 c m ^ as previously 
described (Yue et al., 2008). Cells reached confluency af ter 9 to 10 days w i th a 
resistance greater than lOOQ . c m l The reagents in cell cul ture were obta ined f rom 
Invitrogen (NY, USA). 
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2.4 Short-Circuit Current ( y Measurement 
16HBE140- cells were grown on 0.2 cm^ Transwell-COL fi l ters for 9 to 10 days 
unti l conf luent , as previously described (Yue et al., 2008) (Fig. 2.4.1). The seeding 
density was 3 x lO* cel ls/wel l (i.e. 3 x 10^ cel ls/ml) Then the cell monolayers were 
mounted in re-circulating Ussing chambers in which they were bathed in 
bicarbonate-buffered Krebs-Henseleit (K-H) solut ion at 37。C and 95% oxygen/ 5% 
carbon dioxide so as to maintain pH at 7.4 (Fig. 2.4.2 to Fig. 2.4.4). The electrodes 
(World Precision Instruments Inc., USA) used in the Ussing chambers were made o f 
3% agarose dissolved in 3 M KCI solut ion. A basolateral-to-apical CI" gradient was 
set-up across the monolayer by changing the normal K-H solut ion at the apical side 
w i th low c r K-H solut ion, since this gradient could facil i tate CI" secretion f rom the 
monolayer. The trans-epithel ial potent ia l di f ference was clamped at 0 mV. A 
trans-epithel ial potent ial dif ference of 1 mV was appl ied to the monolayer th rough 
voltage electrodes at regular t ime intervals. Change in Uc was measured by a 
voltage-clamp ampl i f ier (VCC600, Physiologic Instruments, San Diego, CA, USA). The 
changes in current were obtained to calculate trans-epithel ia l resistance of the 
monolayer using the Ohm's law. Conventionally, posit ive current which gave an 
upward def lect ion in electrical trace record would be considered as anions moved 
f rom basolateral compar tment to apical compar tment o f the cell. For studying the 
effect of drugs on Uc responses, CM extract, cordycepin or d i f ferent channel blockers 
and Inhibitors were added to apical or basolateral side of 16HBE14o- monolayer. 
24 
Silica n 
Well for Holding • 
Cell Suspension 
Transwell-COL • 
Fig. 2.4.1 一 The top (upper) and the bottom (lower) side of a Transwell-COL filter. 
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Fig. 2.4.3 - The half-chambers and electrodes in re-circulating Ussing chamber. 
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Fig. 2.4.4 - Simplified diagram of re-circulating Ussing chamber. Constant 
trans-epithel ial voltage (1 mV) was appl ied to the system th rough t w o voltage 
electrodes (blue in colour). The change In Isc wou ld be measured by t w o current 
electrodes nearby (red in colour) (Adapted f rom Instruct ion manual of Ussing system, 
Wor ld Precision Instruments, 2002). 
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2.5 Short-Circuit Current ( y Measurement in Nystatin-Permeabilized 
Monolayer 
16HBE140- monolayers were mounted in the re-circulating Ussing chambers 
bathed in bicarbonate-buffered Krebs-Henseleit (K-H) solut ion, as previously 
described in Chapter 2.4. For the measurement of apical CI" current lci(ap), an 
apical-to-basolateral C「gradient was set-up across the 16HBE14o- monolayer. The 
reversed CI" gradient produced inverted current f rom basolateral to apical 
compar tment , so as to ensure that the current was generated by opening of CI" 
channels only. In order to set up this gradient, NaCi was replaced by equimolar 
Na-gluconate in basolateral K-H solut ion (i.e. CI-free solution) (Anderson et al., 1991). 
The basolateral side of the monolayer was permeabil ized by 360 pig/ml nystatin for at 
least 45 minutes before the addit ion of cordycepin, CM extract or channel blockers 
(Fig. 2.5.1). Nystatin is a polyene antifungal drug that produces pores on cell 
membrane. The nystatin pores are 0.8 nm in diameter, which are permeable to 
monovalent cations and (T ions. Thus, nystatin permeabil ization is performed to 
bypass basolateral membrane for lci(ap) measurement (Li et al., 2004). 
Similarly, for the measurement of basolateral K+ current 
basolateral-to-apical K+ gradient was set-up across the 16HBE14o- monolayer. In 
order to set up this gradient, NaCI was replaced by equimolar K-gluconate in apical 
K-H solution. In addit ion, NaCI was replaced by equimolar Na-gluconate in 
basolateral K-H solution. The apical side of the monolayer was permeabilized by 360 
阳 / m l nystatin for at least 45 minutes before the addit ion of cordycepin, CM extract 
or channel blockers. Nystatin permeabil ization is performed to bypass apical 
membrane for 1 _ ) measurement. 
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Fig. 2 .5.1 - Molecular structure of nystatin (Adapted f rom Wikipedia - "Nystat in") . 
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2.6 Measurements of [Ca^^ Jj 
16HBE140- cells were seeded onto the surface o f a microscope cover glass 
(Thermo Scientific, Germany). The cover glass (2.5 cm in d iameter) had been already 
steril ized by burning w i th 95% ethanol in Bunsen f lame. Each piece o f steril ized cover 
glass was placed in a small petr i dish (3.5 cm in d iameter) . The cells were g rown on 
the surface of cover glass for 3 to 4 days. The seeding density was 1 x 10^ cells/glass 
(i.e. 1 X 104 cel ls/ml). On the day of exper iment , the cul ture med ium was removed. 
The cover glass was washed w i th normal K-H solut ion. Then the cells was loaded w i th 
3 piM Fura-2-AM, 1.6 piM pluronic F127 and 2 .5mM probenecid (in 0 .5M NaOH) 
dissolved in normal K-H solut ion and incubated at 37°C and humidi f ied atmosphere 
w i t h (5% carbon dioxide) for 45 minutes. Pluronic F127 acted as a non-ionic 
surfactant polyol to facil i tate water- insoluble dyes to be more soluble in aqueous 
solut ion (Borin et al., 1990). On the o ther hand, probenecid was used to inhibi t 
organic anion t ranspor t so as to minimize the leakage o f dye (Enomoto et al., 2002). 
Thus, the f luorescence dyes wou ld be more evenly distr ibuted in the loaded cells. 
The dye-loaded cells were mounted in a perfusion chamber over an inverted 
microscope. The cells were focused under a long work ing distance object ive w i t h 
magnif icat ion o f 40X. In order to determine [Ca^^j , the dye-loaded cells were excited 
by t w o wavelengths - 340 nm and 380 nm, emi t ted f rom the Xenon arc lamp 
alternat ively at 20 t imes per second. The emission wavelength 520 nm was collected 
in a photomul t ip l ie r tube. The emission intensities f r om 340 nm and 380 nm 
excitations were recorded by PTI Ratio-Master Fluorescence System (Photon 
Technology Internat ional, NJ, USA) (Fig. 2.6.1). In each measurement , about 30 to 40 
cells in the centre of the ceil monolayer were chosen In the optical f ield. At the 
beginning of each measurement, the whole system was stabilized by apical perfusion 
o f 37°C normal K-H solut ion through an in-line heater fo r 5 to 10 minutes. Dif ferent 
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drugs or buffers were appl ied to the system w i t h the use o f valve contro l ler and 
perfusion chamber (Fig. 2.6.2 and Fig. 2.6.3). The changes in emission intensit ies as 
wel l as Fura-2 f luorescence ratio (340 n m / 380 nm) were quant i tat ive ly shown in 
FeliX32 sof tware and recorded in the computer harddisk. 
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• ^ J i 
Chamber Microscope 
Fig. 2.6.1 - Set-up of PTI Ratio-Master Fluorescence System. 
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wKSS/^ 
Buffer Inlet 1 
^ H Buffer Outlet 
Fig. 2.6.2 - Set-up of a perfusion chamber. 
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Outlet mmm^ . 
Z J . \ 
16HBE140- celk W^M ？ 口 轉 
grown on glass slide Fluorescence microscope 40X 
Fig. 2.6.3 - Simplified diagram of a perfusion chamber. 
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2.7 Measurement of PKA Activity 
16HBE140- cells were grown on 6-wel l plates for 6 to 7 days unt i l conf luent . The 
seeding density was 3 x 10^ cel ls/wel l (i.e. 3 x 10^ cel ls/ml). On Day 6, the cells were 
incubated w i th serum-free M i n i m u m Essential Med ium overnight . At one hour 
before the start o f exper iment , the cells were incubated w i t h normal K-H solut ion. 
When the exper iment began, they were incubated w i th K-H solut ion alone (as 
vehicle control) , 100 ng /m l CM water extract or 10 | iM cordycepin for 5 and 15 
minutes. Af ter incubation, the cells were washed twice by ice-cold I X phosphate 
buffered saline (PBS). They were lysed by 120 |il lysis buffer and collected in labeled 
microcentr i fuge tubes. The intracellular PKA activi ty was de termined w i th the use of 
PepTag® non-racMoactive cAMP-dependent protein kinase assay kit (Promega, 
Madison, Wl , USA) as previously described (Yue et ai, 2004). The phosphorylated 
and non-phosphorylated synthetic Kemptide (Leu-Arg-Arg-Ala-Ser-Leu-Gly) samples 
were separated on 0.8% agarose gel at 100 V for 15 minutes. The image o f the gel 
was captured and its f luorescence intensity was quant i f ied by the FluorChem^'^ 8000 
imaging system (Cell Biosciences, Inc., Santa Clara, CA, USA). 
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2.8 Statistical Analysis 
Experimental- induced changes (A ) in f luorescence ratio and Uc were quant i f ied 
by measuring each parameter at the peak o f response and subtract ing the equivalent 
values measured immediate ly pr ior t o st imulat ion. Pooled data were presented as 
mean ± standard error (S.E.), and the values o f n represent the number o f 
exper iments in each group. The dif ferences o f data between control and 
exper imental group were analyzed by Student's t-tests w i t h unpaired variants or 
one-way AN OVA where appropr iate, w i t h p < 0.05 considered as signif icant 
(GraphPad Software Inc., CA, USA). 
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Chapter 3 Results 
3.1 Regulation of Ion Transport in 16HBE14o- Cells by CM Water 
Extract 
In order t o investigate the intracellular mechanisms in regulat ing trans-epithel ial 
ion t ranspor t induced by CM water extract, d i f ferent channel blockers and inhibi tors 
were appl ied to conf luent 16HBE14o- monolayer together w i t h CM extract for 
measuring the change in I sc. 
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3.1.1 Dose-Dependent Relationship of CM Water Extract 
At the beginning of the project, the propert ies o f CM water extract in 
st imulat ing trans-epithel ial ion t ranspor t across 16HBE14o- cells have to be 
characterized. Experiments were per formed to exam whe the r the extract could 
st imulate an increase in Uc in 16HBE14o- cells. The change in Uc af ter the addi t ion o f 
CM extract was recorded by a vo l tage/current c lamp amplif ier, which reflects the 
electrogenic ion t ranspor t across the epi thel ia. The epithel ia were st imulated by 
d i f ferent concentrat ions of CM extract so as to construct the dose-response curves 
for bo th apical and basolateral compar tments . 
The basal Isc and trans-epithel ial resistance (TER) of 16HBE14o- cells was 
67.8±1.8 nA/cm^ and 143.4±4.3 Q x m ^ respectively (n 二 244). Fig. 3.1.1.1 showed the 
change in Uc af ter the appl icat ion o f 100 昭 / m l CM water extract at both apical (ap) 
and basolateral (bl) sides, respectively. There was an increase In Uc w i th in 5 minutes 
af ter CM extract st imulat ion at both sides o f 16HBE14o- epithel ia (For 100 [xg/m\ CM 
extract. Apical: 22.9±2.8 ^lA/cm^; Basolateral: 14.1±1.6 | iA / cm^ n : 6-10). The Isc then 
decl ined towards the basal level slowly. On the o ther hand. Fig. 3.1.1.2 shows the 
dose-response curves of CM extracts at t w o sides o f 16HBE14o- monolayer. The half 
maximal effect ive concentrat ion (EC50) o f CM Extract was 12.1 昭 / m l and 12.4 | i g /m l 
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Fig. 3.1.1.1 - Representative trace records of Uc in response to apical (left) and 
basolateral (right) application of 100 pig/ml CM extract. The do t ted line represents 
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Fig. 3.1.1.2 - Dose-response curves for change in Uc by CM extract loaded apically 
( # ) or basolaterally ( • ) in confluent 16HBE14o- epithelia. Changes in Uc were 
plot ted against the logari thm of concentrat ion o f CM extract used (n = 5-11). Each 
data point represents the mean 土 S.E. 
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3.1.2 Involvement of CI Transport in CM-induced Isc Response 
In normal epi thel ia l cells, CI" ions enter the cells th rough NKCCl across the 
basolateral membrane. Then they are secreted th rough CFTR and CaCC to the apical 
side. In previous research, CM extract s t imulates an increase in anion secretions in 
Calu-3 cells. It was found tha t CI" ions were Impor tant in anion secretions (Yue et al., 
2008). Since CM extract could st imulate an increase in Uc in 16HBE14o- cells, 
exper iments were per formed t o ascertain wh ich types of CI" channels mediates the 
s t imulat ion of anion secret ion caused by CM extract. 
The cell monolayers were pret reated w i t h specific CI" channel blockers at least 5 
minutes before the addi t ion o f 100 ^ g / m l CM extract for de te rmina t ion o f the 
change in Isc- The CI" channel blockers were CFTR.jnhi72 (10 piM), a CFTR channel 
blocker and DIDS (300 \xW\), a Ca^^-actlvated CI" channel (CaCC) blocker. In addi t ion, 
Bumetanide (100 _ ) , a Na+-K+-2C|- co- t ransporter (NKCCl) inhibitor, was used to 
access the invo lvement of CI' uptake mediated by NKCCl at the basolateral 
membrane. 
Fig. 3.1.2.1 and Fig. 3.1.2.2 showed the typical tracings of Isc in response to 
appl icat ion of 100 | i g /m l CM extract at e i ther side of 16HBE14o- epithel ia, w i t h or 
w i t h o u t p re t rea tment o f CI. channel blockers. Add i t ion o f CFTR.inhi72 to apical side of 
the monolayer reduced the basal Isc by 7.8±1.4 piA/cm^, showing that the CI" channels 
were already act ivated w h e n the cells were under resting stage. In the presence of 
CFTR-inhi72, the CM-induced Isc was reduced by 47.6% and 79.4% at apical (Fig. 
3.1.2.1B; Control (ap): 22.9±2.8 piA/cm^; +CFTR.inhi72： 12.0±2.4 | iA/cm^; p < 0.05, n 二 5) 
and basolateral side (Fig. 3.1.2.2B; Control (bl): 14.1 土 1.6 piA/cm^; +CFTR.inhi72: 2.9±0.6 
piA/cm^; p < 0.05, n = 6), respectively. 
On the o ther hand, addi t ion of DIDS reduced the basal Isc by 24.3±1.8 piA/cm). In 
the presence of DIDS, the CM-induced Isc was lowered by 50.3% and 40.6% at apical 
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(Fig. 3.1.2.1C; Control (ap): 22.9±2.8 ^A/cm^; +DIDS: 11.4±1.5 piA/cm^; p < 0.05, n = 9) 
and basolateral side (Fig. 3.1.2.2C; Control (bl): 14.1±1.6 piA/cm^; +DIDS: 8.4±1.0 
kiA/cm^; p < 0.05, n = 7), respectively. 
The basal Isc was not affected when Bumetanide was added to t he basolateral 
side o f the monolayer. In the presence of Butmetanide, the CM-induced Uc was 
reduced by 33.8% and 54.9% at apical (Fig. 3.1.2.1E; Control (ap): 22.9±2.8 nA/cm^; 
+Bumetanide: 15.2土 1.8 piA/cm?; p < 0.05, n = 7) and basolateral side (Fig. 3.1.2.2E; 
Control (bl): 14.1±1.6 | iA/cm^; +Bumetanide: 6.4±1.5 piA/cm^; p < 0.05, n = 10), 
respectively. 
Moreover, exper iments were conducted to test if CFTR.jnhm and DIDS wou ld 
have synergistic effect on inhibi t ing CM-induced Isc- 16HBE14o- cells were pretreated 
w i th both blockers for at least 5 minutes before CM st imulat ion. The Inhibi tory effect 
appeared to be larger when these t w o blockers were added t o 16HBE14o- epithel ia. 
The CM-induced Uc response was reduced by 62.5% and 97.1% at apical (Fig. 3 .1 .2 . ID; 
Control (ap): 22.9±2.8 ^A/cm〗； +CFTR.jnhi72 and DIDS: 4.5±0.9 piA/cm^; p < 0.05, n = 5) 
and basolateral side (Fig. 3.1.2.2D; Control (bl): 14.1±1.6 ^lA/cm^; +CFTR.inhi72 and 
DIDS: 0.4±0.4 | iA/cm^; p < 0.05, n 二 6), respectively. However, the combined effect of 
two blockers was not significantly greater than the i r individual effect (p > 0.05, 
One-way AN OVA). The summarized results are shown In Fig. 3.1.2.3. 
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CFTR-inhl72(10 ptM) CM Extract (AP) Bumetanide (BL) CM Extract (AP) 
+ DIDS{300 uM)(AP) (100 ^ig/ml) (100 jiM) (100 Mg/ml) 
Fig. 3.1.2.1 - Representative recordings of Isc in response to apical application of 100 
Ug/ml CM extract in control epithelia (A) or in the presence of 10 jiM CFTR_inhi72 (B), 
300 ^M DIDS (C), CFTR.inhi72 together with DIDS (D) and 100 piM Bumetanide (E). 
The blockers and inhibitors were applied for at least 5 minutes before the addi t ion of 
CM extract. The dot ted line represents the zero current level. 
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Fig. 3.1.2.2 - Representative recordings of U in response to basolateral application 
of 100 ng/ml CM extract in control epithelia (A) or in the presence of 10 nM 
CFTR.inhi72 (B), 300 nM DIDS (C), CFTR“nhi72 together with DIDS (D) and 100 piM 
Bumetanide (E). The blockers o r inhib i tors we re appl ied for at least 5 minutes before 
the add i t ion o f CM extract . The do t ted line represents the zero cur rent level. 
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Fig. 3.1.2.3 - Summarized data showing the effect of CI" channel blockers and NKCCl 
inhibition on CM-induced Uc Control was the apical or basolateral appl icat ion o f CM 
extract alone. Each co lumn represents the mean 土 S.E. ( *p < 0.05, * * p < 0.01, * * * p < 
0.001, Student's t-test compared w i th control , n = 5-10). However, there are no 
significant dif ferences between single-blocker and two-b locker- t reated groups (p > 
0.05, One-way ANOVA). 
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3.1.3 Involvement of K+ channels in CM-induced Uc Response 
The basolateral membrane of epi thel ia l cells contains d i f ferent K+ channels. 
Act ivat ion o f these K+ channels wi l l hyperpolarize the membrane, wh ich is 
responsible for dr iv ing apical CI" exit. In order to access the role of d i f ferent classes o f 
K+ channels in CM-induced Uc, exper iments investigated the inhibi tory act ion of K+ 
channel blockers on CM-st imulated Uc in 16HBE14o- epi thel ia. The cell monolayers 
were pretreated w i th some specific K+ channel blockers for at least 5 minutes, before 
the addi t ion of 100 pig/ml CM extract. The blockers used were TRAM-34 (10 piM), a 
Ca2+-activated K+ channel (KCNN4) blocker; and Chromanol 293B (10 piM), a 
cAMP-act ivated K+channel (KvLQTl) blocker. 
Fig. 3.1.3.1 and Fig. 3.1.3.2 show the typical tracings o f Isc af ter the appl icat ion 
of 100 pig/ml CM extract at ei ther side o f 16HBE14o- epithel ia, w i t h or w i t hou t 
pre t reatment of K+ channel blockers. The basal Uc did not change w h e n TRAM-34 or 
Chromanol 293B was added to the basolateral side o f the monolayer, showing tha t 
the K+ channels were not active when the cells were under resting stage. 
For the apical side, the CM-induced Uc was reduced by 38.2% and 44.4% by 
TRAM-34 (Fig. 3.1.3. IB; Control (ap): 22.9±2.8 MA/cm^; +TRAM-34: 14.2±2.1 piA/cm^; 
P < 0.05, n = 6) and Chromanol 293B (Fig. 3.1.3.1C; Control (ap): 22.9±2.8 piA/cm^; 
+Chromanol 293B: 12.8±3.5 piA/cm^; p < 0.05, n = 5), respectively. However, these 
two blockers could not inhibi t the CM-induced Isc response at the basolateral side o f 
16HBE140- monolayer significantly. (Fig. 3.1.3.2B; Control (bl): 14.1±1.6 nA/cm^; 
+TRAM-34: 11.5±1.8 piA/cm^' Fig.3.1.3.2C; Control (bl): 14.1±1.6 ^A/cm^; 
+Chromanol 293B: 10.0±3.2 piA/cm^; p > 0.05, n 二 5-6). 
Experiments were per formed to determine whether TRAM-34 and Chromanol 
293B wou ld have a synergistic effect on inhibi t ing CM-induced l^ c- 16HBE14o- cells 
were pretreated w i th both blockers for at least 5 minutes before CM st imulat ion. The 
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inhib i tory effect appeared to be larger w h e n these t w o blockers were added to 
16HBE140- epithel ia that CM-induced Isc response reduced by 83.5% and 64.6% at 
apical (Fig. 3 .1 .3 . ID; Control (ap); 22.9±2.8 piA/cm^; +TRAM-34 and Chromanol 293B: 
2.5±0.5 piA/cm^- p < 0.05, n = 4) and basolateral side (Fig. 3.1.3.2D; Control (bl): 
14.1±1.6 kiA/cm^; +TRAM-34 and Chromanol 293B: 5.0±0.5 piA/cm^; p < 0.05, n = 4), 
respectively. However, the combined effect of t w o blockers was not signif icantly 
greater than the i r individual effect (p > 0.05, One-way ANOVA). The summarized 
results were shown in Fig. 3.1.3.3. 
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Fig- 3.1.3.1 - Representative recordings of Isc in response to apical application of 100 
pig/ml CM extract, in control epithelia (A) or in the presence of 10 piM TRAM-34 (B) 
or 10 n M Chromanol 293B (C) and two blockers added together (D). The blockers 
were applied for at least 5 minutes before the addit ion of CM extract. The dot ted line 
represents the zero current level. 
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Fig. 3.1.3.2 - Representative recordings of Isc in response to basolateral application 
of 100 jig/ml CM extract, in control epithelia (A) or in the presence of 10 piM 
TRAM-34 (B) or 10 \iM Chromanol 293B (C) and two blockers added together (D). 
The blockers were appl ied for at least 5 minutes before CM st imulat ion. The dot ted 
line represents the zero current level. 
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Fig. 3.1.3.3 - Summarized data showing the effect of iC channel blockers on 
CM-induced Isc Control was the apical or basolateral application of CM extract alone. 
Each column represents the mean 土 S.E. ( *p < 0.05, * * p < 0.01, * * * p < 0.001, 
Student's t-test compared w i th control , n 二 6-9). However, there are no signif icant 
dif ferences between single-blocker and two-blocker- t reated groups (p > 0.05, 
One-way ANOVA). 
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3.1.4 Involvement of Adenylate Cyclase/cAMP/Protein Kinase A 
Pathway in CM-induced Isc Response 
From the previous exper iments, it was shown that cAMP-dependent channels 
(e.g. CFTR, KvLQTl) were activated w h e n CM extract was appl ied to 16HBE14o- cells. 
The data suggested tha t cAMP-de pen dent pathways wou ld be Involved in 
CM-induced Uc response. To fu r ther elucidate the Involvement o f adenylate cyclase 
(AC), cAMP/PKA pathway In response to CM, the ef fect o f the AC inhibitor, 
MDL-12330A (1 ^ M ) and PKA inhibi tor H89 (1 piM) was examined. The inhibi tors 
were appl ied to cell monolayers for 15 minutes before CM st imulat ion to determine 
the change in Isc. 
Fig. 3.1.4.1 and Fig. 3.1.4.2 show the typical tracings of Uc after the appl icat ion 
of 100 n g / m l CM extract at e i ther side of 16HBE14o- epithel ia, w i t h or w i t h o u t 
pre t reatment o f cAMP-dependent pathway inhibitors. The basal Uc did not change 
when IV1DL-12330A was added to the apical side o f the monolayer. The CM-induced 
Isc was reduced by 37.8% and 46.9% at apical (Fig. 3.1.4.1B; Control (ap): 22.9±2.8 
^A/cm^- +MDL-12330A: 12.8±3.5 ^A/cm^; p < 0.05, n = 5) and basolateral side (Fig. 
3.1.4.2B; Control (bl): 14.1±1.6 piA/cm^' +MDL-12330A: 7.5±0.4 piA/cm^- p < 0.05, n : 
5), respectively. 
The basal Isc did not change when H89 was added to the apical side of the 
monolayer. The CM-induced Uc was reduced by 47.1% and 62.6% at apical (Fig. 
3.1.4.1C; Control (ap): 22.9±2.8 piA/cm^- +H89: 12.13±1.93 [xA/cm^; p < 0.05, n : 10) 
and basolateral side (Fig. 3.1.4.2C; Control (bl): 14.1±1.6 piA/cm^; +H89: 5.3±0.9 
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Fig. 3.1.4.1 - Representative recordings of Uc in response to apical application of 100 
|ig/ml CM extract. In the absence (A) or presence of 1 nM MDL-12330A (B) or 1 piM 
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H89 (C). The inhibitors were applied fo r 15 minutes before the addi t ion of CM extract. 










t f t 
CM Extract (BL) MDL-12330A (AP) CM Extract (BL) 






H89 (AP) CM Extract (BL) 
( l l iM ) (100 jig/ml) 
Fig. 3.1.4.2 - Representative recordings of Isc in response to basolateral application 
of 100 ng/ml CM extract, in the absence (A) or presence of 1 piM MDL-12330A (B) 
or 1 j i M H89 (C). The inhibitors were applied for 15 minutes before the addi t ion of 
CM extract. The dot ted line represents the zero current level. 
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Fig. 3.1.4.3 - Summarized data showing the effect of MDL-12330A and H89 on Uc 
response to CM extract. Control was the apical or basolateral appl icat ion o f CM 
extract alone. Each co lumn represents the mean 土 S.E. ( *p < 0.05, * * p < 0.01, * * * p < 
0.001, Student 's t- fest compared w i th contro l , n = 5-10). 
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3.1.5 Involvement of Ca^^-Dependent Pathway in CM-induced Uc 
Response 
The inhib i tory effect of DIDS and TRAM-34 in CM-induced l^ c suggested tha t 
Ca2+-dependent ion channels (e.g. CaCC, KCNN4) are involved in mediat ing CI" across 
16HBE140- epi thel ia. To study the involvement o f intracellular Ca^^ in the Isc in 
response to CM, the 16HBE14o- monolayer was loaded w i th the cel l -permeant Ca^^ 
chelator BAPTA-AM (50 _ for 45 minutes before CM st imulat ion. 
Fig. 3.1.5.1 and 3.1.5.2 showed the typical tracings of Isc af ter the appl icat ion o f 
100 pig/ml CM extract at ei ther side of 16HBE14o- epithel ia, w i t h or w i t h o u t 
pre t reatment o f BAPTA-AM. The basal Uc did not change when BAPTA-AM was added 
to the basolateral side of the monolayer. The CM-induced Isc was reduced by 57.5% 
and 61.1% at apical (Fig. 3.1.5. IB; Control (ap): 22.9±2.8 piA/cm^; +BAPTA-AM: 
9.8±1.6 nA/cm^' p < 0.05, n = 5) and basolateral side (Fig. 3.1.4.2B; Control (bl): 
14.1±1.6 piA/cm^; +BAPTA-AM: 5.5±0.9 piA/cm^- p < 0.05, n 二 5), respectively. The 
summarized results were shown in Fig. 3.1.5.3. 
However, the CM water extract contained yel low-colored pigments tha t might 
interfere w i t h the accurate measurement o f Fura-2 f luorescence ratio. Thus, it was 
not practical to determine the change in intracellular Ca^"" concentrat ions using 
microf luor imetr ic techniques (See Chapter 3.2.6). 
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Fig. 3.1.5.1 - Representative recordings of Uc in response to apical application of 100 
pig/ml CM extract, in the absence (A) or presence of 50 ^M BAPTA-AM (B). The 
inhibi tor was appl ied for 45 minutes before the addi t ion of CM extract. The dot ted 
line represents the zero current level. 
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Fig. 3.1.5.2 - Representative recordings of Isc in response to basolateral application 
of 100 jig/ml CM extract, in the absence (A) or presence of 50 nM BAPTA-AM (B). 
The inhibi tor was appl ied for 45 minutes before the addi t ion of CM extract. The 
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Fig. 3.1.5.3 - Summarized data of the effect of BAPTA-AM on CM-induced Isc 
response. Control was the apical or basolateral appl icat ion of CM extract alone. Each 
column represents the mean 土 S.E. ( * * p < 0.01, Student's t-test compared w i t h 
control , n = 5-10). 
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3.1.6 Effect of CM Extract on Apical CI" Current and Basolateral K+ 
Current in Nystatin-Permeabilized Epithelia 
In intact epithel ia the Isc is a measure of the net active ion t ranspor t across both 
apical and basolateral membranes. In order to selectively investigate electrogenic 
t ranspor t via apical membrane, exper iments were per formed to bypass the 
basolateral membrane of the epithel ia. For this purpose, the basolateral membrane 
was permeabil ized by 360 pig/ml nystatin for at least 45 minutes. Af ter the 
permeabi l izat ion process, an asymmetr ical CI— gradient was set-up across the intact 
apical membrane before 100 阳 / m l CM st imulat ion for determinat ion of apical CI' 
current . 
Similarly, the addi t ion o f CI" channel blockers reduced the basal current by 
7.8±1.4 | iA/cm2 (CFTR_inhi72 10 ^ M ) and 24.3±1.8 piA/cm^(DIDS 300 ^M) . Af ter the 
establ ishment of apical-to-basolateral CI" gradient and permeabi l izat ion of 
basolateral membrane, pre t reatment o f CFTR.jnhm (Fig. 3.1.6.IB) or DIDS (Fig. 
3.1.6.1C) could inhibi t CM-induced apical CI" current lci(ap) in permeabil ized epithel ia 
(Fig. 3.1.6.1A) by 56.7% (Control (ap): -9.4土 1.2 ^A/cm^; +CFTR.inhi72： -4.1±0.6 piA/cm^; 
p < 0.05, n = 4 ) and 66.7% (Control (ap): -9.4±1.2 piA/cm^; +DIDS: -3.1±0.7 nA/cm^; p 
< 0.05, n 二 6), respectively. The summarized results were shown in Fig. 3.1.6.3. 
On the o ther hand, in order to selectively study the electrogenic t ransport via 
basolateral membrane, exper iments were per formed to bypass the apical membrane 
of the epithel ia. The apical membrane was permeabil ized by 360 pig/ml nystatin for 
at least 45 minutes. Af ter the permeabi l izat ion process, an asymmetr ical K+gradient 
was set-up across the intact basolateral membrane before 100 昭 / m l CM st imulat ion 
for determinat ion of basolateral K+current. 
Addi t ion of K+ channel blockers would not change the basal current. Af ter the 
establ ishment of apical-to-basolateral K+ gradient and permeabi l izat ion of apical 
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membrane, pre t reatment of 10 piM TRAM-34 (Fig. 3.1.6.2A) or 10 piM Chromanol 
293B (Fig. 3.1.6.2B) could inhibi t the increase in basolateral K+ current l _ ) in 
permeabi l ized epithel ia (Fig. 3.1.6.2C) by 95.1% (Control (bl): 12.7±1.9 ^A/cm^; 
+TRAM-34: 0.6±0.4 piA/cm^;p < 0.05, n = 4) and 68.0% (Control (bl): 12.7±1.9 piA/cm^-
+Chromanol 293B: 4.1±0.8 | iA/cm^; p < 0.05, n = 4), respectively. The summarized 
results were shown in Fig. 3.1.6.4. 
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CM Extract (AP) CFTR-inhi72 (AP) CM Extract (AP) 
(100 lig/ml) ( lOfiM) (lOOiig/mi) 





DIDS (AP) CM Extract (AP) 
(300 |iM) (100 tig/ml) 
e 1 1 7 
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Fig. 3.1.6.1 - Representative trace records of lci(ap) after application of 100 pig/ml 
CM extract, in the absence (A) or presence of 10 nM CFTR_inhi72 (B) or 300 nM DIDS 
(C). The basolateral membrane has been permeabil ized by 360 pig/ml nystatin for at 
least 45 minutes before addi t ion of CM extract. The dot ted line represents the zero 
current level. 
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Fig. 3.1.6.2 - Representative trace records of iK(bi) after application of 100 ng/ml CM 
extract, in the absence (A) or presence of 10 nM TRAM-34 (B) or 10 ^M Chromanol 
293B (C). The apical membrane has been permeabilized by 360 | ig /ml nystatin for at 
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Fig. 3.1.6.3 - Summarized data showing the effect of CI" channel blockers on apical 
cr conductance induced by CM extract. Control was the apical application of CM 
extract alone. Each co lumn represents the mean 土 S.E. ( *p < 0.05, * * p < 0.01, 
Student's t-test compared w i th control , n = 4-6). 
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Fig. 3.1.6.4 - Summarized data showing the effect of K+ channel blockers on 
basolateral K+ conductance induced by CM extract. Control was the basolateral 
appl icat ion of CM extract alone. Each co lumn represents the mean 土 S.E. ( * * p < 0.01, 
* * * p < 0.001, Student's t-test compared w i th control , n = 4-8). 
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3.1.7 Effect of CM Extract on PKA Activity 
To fu r ther substantiate the involvement o f AC/cAMP/PKA pathway in mediat ing 
the CM-induced Isc response, PKA activit ies In 16HBE14o- cells were measured by 
PepTag® non-radioact ive cAMP-dependent protein kinase assay kit. The conf luent 
16HBE140- cells were t reated w i th 100 pig/ml CM extract or 10 | iM UDP, an act ivator 
of AC/cAMP/PKA pathway in 16HBE14o- cells (Wong et al., 2009). When PKA was 
activated, it wou ld phosphorylate the highly specific f luorescent synthetic pept ide 
substrate. Phosphorylat ion of pept ide alters the net charge f r om +1 to -1. During 
electrophoresis, these phosphorylated pept ides move towards the positive termina l 
of the power supply. The higher f luorescence level represents higher PKA activit ies. 
Fig. 3.1.7.1 showed the image of the 0.8% agarose gel o f a typical PKA assay. In 
this photo, cells were t reated w i t h ei ther vehicle alone (control, lane 1), CM extract 
(5 minutes: lane 2, 15 minutes: lane 3); or UDP (10 minutes, lane 4). The negative 
and positive controls provided by the PKA assay kit were shown in lane 5 and 6. The 
assay results (Fig. 3.1.7.2) suggested that CM extract was able to signif icantly 
increase intracellular PKA activit ies by 71.5% (5 minutes t reatment ) and 46.6% (15 




Fig. 3.1.7.1 - Image of 0.8% agarose gel of a typical PKA assay after CM stimulation. 
Descript ions for each lane: Lane 1 (Control, vehicle alone); Lane 2 (100 | i g /m l CM 
extract, 5 minutes); Lane 3 (100 j i g / m l CM extract, 15 minutes); Lane 4 (100 piM UDP, 
10 minutes); Lane 5 (PKA assay kit negative control) ; Lane 6 (PKA assay kit posit ive 
control ) . A f te r electrophesis, the synthetic pept ides in the react ion mix ture were 
separated into t w o groups: Non-phosphory la ted pept ides (Posit ively-charged) moved 
towards the negative te rmina l of power supply (The upper row); phosphory la ted 
pept ides (Negatively-charged) moved towards the posit ive te rmina l of pwer supply 
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Fig. 3.1.7.2 - Summarized data showing the relative intracellular PKA activity 
stimulated by CM extract. Control was the t rea tment of vehicle (K-H solut ion) alone. 
The intracellular PKA activit ies in t reated cells were compared to tha t in the control 
cells, thus the relative PKA activity of the control cells wou ld be counted as 1. Each 
column represents the mean 土 S.E. ( *p < 0.05, * * p < 0.01, Student's t-test compared 
w i th control , n = 5). 
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3.2 Regulation of Ion Transport in 16HBE14o- Cells by Cordycepin 
CM extract has a higher amount o f cordycepin (0.2480% by weight) than o ther 
Cordyceps species (e.g. none in Cordyceps sinensis extract) (Yue et al., 2008). 
Experiments were conducted to test if this pure compound could affect ion t ranspor t 
as wel l as signal t ransduct ion pathway in conf luent 16HBE14o- epithel ial cells. 
3.2.1 Dose-Dependent Relationship of Cordycepin 
Similarly, the propert ies of cordycepin have to be characterized f irst. 
Experiments were per formed to determine whe ther the compound could st imulate 
an increase in Uc in 16HBE14o- cells. Again, change in Isc af ter appl icat ion of 
cordycepin was recorded by a vol tage/current ampli f ier. Dose-response curves for 
apical and basolateral membranes were constructed by st imulat ing the epithel ia w i t h 
d i f ferent concentrat ions o f cordycepin. 
In this series o f experiments, the basal Uc and TER of 16HBE14o- cells was 
77.9±2.4 ^lA/cm^ and 111,8±3.6 Q.cm^, respectively (n 二 138), which were similar to 
the cells used in Chapter 3.1.1. Fig. 3.2.1.1 showed the change in Uc after the 
appl icat ion of 10 | iM cordycepin at both apical and basolateral sides. There was an 
increase in Uc w i th in 5 minutes after cordycepin st imulat ion (For 10 piM Cordycepin, 
Apical: 4.4±0.7 piA/cm^; Basolateral: 6.6土0.5 n A / c m ^ n = 8-9). The Isc then decl ined 
towards the basal level very slowly. On the o ther hand. Fig. 3.2.1.2 shows the 
dose-response curves o f cordycepin at t w o sides of 16HBE14o- monolayer. The EC50 
of cordycepin was 8.1 ^iM and 6.5 piM at apical and basolateral side, respectively. 
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Fig. 3.2.1.1 - Representative trace records of Uc in response to apical (left) and 
basolateral (right) application of 10 \iM cordycepin. The dot ted line represents the 
zero current level. 
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Fig. 3.2.1.2 - Dose-response curves for change in Uc by cordycepin added apically 
(# ) or basolaterally ( • ) in confluent 16HBE140- epithelia. Changes in Uc were 
plot ted against the logar i thm of concentrat ion o f cordycepin used (n = 4-9). Each 
data point represents the mean 土 S.E. 
72 
3.2.2 Involvement of CI" Transport in Cordycepin-induced Uc 
Response 
Since cordycepin could s t imulate an increase in Isc in 16HBE14o- cells in a 
dose-dependent manner, exper iments were per fo rmed to examine wh ich types o f CI" 
channels were involved in s t imu la t ion of anion movemen t caused by cordycepin. 
Similarly, the cell monolayers were pret reated w i t h CFTR.inhi72 (10 [iW\) and DIDS (300 
^ M ) for at least 5 minutes, before the add i t ion of 10 | i M cordycepin fo r 
de te rm ina t ion o f the change in Uc. Fig. 3.2.2.1 and Fig. 3.2.2.2 showed the typical 
tracings o f Isc in response to appl icat ion o f 10 | i M cordycepin at e i ther side o f 
16HBE140- epi thel ia, w i t h or w i t h o u t p re t rea tment o f C\' channel blockers. Apical 
add i t ion o f CFTR.inhi72 reduced the basal Uc by 1.6±0.2 ^lA/cm^. In the presence o f 
CFTR-inhi72, the cordycepin- lnduced Uc was lowered by 88.8% and 76.2% at apical (Fig. 
3 .2 .2 . IB ; Contro l (ap): 4.4±0.7 l iA/cm^; +CFTR.inhi72： 0.5±0.3 piA/cm^; p < 0.05, n = 5) 
and basolateral side (Fig. 3.2.2.2B; Contro l (bl): 6.6±0.5 ^A/cm?; +CFTR.inhi72： 1.6土0.3 
^A/cm^; p < 0.05, n 二 4), respectively. On the o ther hand, add i t ion of DIDS reduced 
the basal Uc by 61.1±5.7 piA/cm^. A f te r the p re t rea tment o f DIDS, the 
cordycepin- induced Isc was lowered by 76.6% and 76.2% at apical (Fig. 3.2.2.1C; 
Contro l (ap): 4.4±0.7 [xA/cro^; +DIDS: 1.0土0.2 piA/cm^; p < 0.05, n = 6) and basolateral 
side (Fig. 3.2.2.2C; Control (bl): 6.6土0.5 piA/cm^; +DIDS: 1.6±0.3 [ lA/cm^; p < 0.05, n 二 
4), respectively. 
Exper iments were per formed to investigate whe the r CFTR.inhi72 and DIDS wou ld 
have synergistic ef fect on inhib i t ing cordycepin- induced Isc. 16HBE14o- epi thel ia were 
pret reated w i t h bo th blockers fo r at least 5 minutes before cordycepin s t imulat ion. 
The inh ib i tory ef fect appeared to be larger w h e n these t w o blockers were added to 
16HBE140- epi thel ia. The cordycepin- induced Isc response was reduced by 93.0% and 
95.2% at apical (Fig. 3 .2.2. ID; Control (ap): 4.44±0.69 piA/cm^; .CFTR-inhm and DIDS: 
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0.3±0.3 [ lA/cm^; p < 0.05, n = 4) and basolateral side (Fig. 3.2.2.2D; Contro l (bl): 
6.6±0.5 ^lA/cm^; +CFTR.inhi72 and DIDS: 0.3士0.3 ^lA/cm?; p < 0.05, n = 4), respectively. 
However, the combined ef fect o f t w o blockers was no t signif icantly greater than the i r 
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Fig. 3.2.2.1 - Representative recordings of Uc in response to apical application of 10 
HM cordycepin, in control epithelia (A) or in the presence of 10 ^M CFTR_inhi72 (B) or 
300 nM DIDS (C), and both blockers add together (D). The blockers were applied for 
at least 5 minutes before addi t ion of cordycepin. The dot ted line represents zero 
current level. 
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Fig. 3.2.2.2 - Representative recordings of Isc in response to basolateral application 
of 10 jiM cordycepin, in control epithelia (A) or in the presence of 10 ^M CFTIUihm 
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(B) or 300 nM DIDS (C), and both blockers add together (D). The blockers were 
appl ied for at least 5 minutes before the addi t ion of cordycepin. The do t ted line 
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Fig. 3.2.2.3 - Summarized data showing the effect of CI' channel blockers on 
cordycepin-induced Uc- Control was the apical or basolateral appl icat ion of 
cordycepin alone. Each column represents the mean 土 S.E. ( * * p < 0.01, * * * p < 0.001, 
Student's t-test compared w i th control , n = 4-5). However, there are no signif icant 
dif ferences between single-blocker and two-blocker- t reated groups (p > 0.05, 
One-way ANOVA). 
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3.2.3 Involvement of K+ channels in Cordycepin-induced Uc Response 
In epi thel ia l cells, basolateral K+ channels were able t o hyperpolar ize the 
membrane for faci l i tat ing apical CI" secret ions. Since CM extract could act ivate K+ 
channels, exper iments were pe r fo rmed t o test whe the r K+ channels were act ivated 
by cordycepin as wel l . The cell monolayers were pret reated w i t h TRAM-34 (10 piM) 
or Chromanol 293B (10 ^ M ) for at least 5 minutes, before the add i t ion of 10 \xW\ 
cordycepin. 
Fig. 3.2.3.1 and Fig. 3.2.3.2 showed the typical tracings o f Isc af ter apical 
appl icat ion of 10 | i M cordycepin, w i t h or w i t h o u t p re t rea tment o f K+ channel 
blockers. Add i t i on of TRAM-34 or Chromanol 293B to t he basolateral side o f the 
monolayer d id no t change the basal current level. In the presence o f TRAM-34, the 
cordycepin- induced Isc was reduced by 67.2% and 58.1% at apical (Fig. 3 .2 .3 . IB ; 
Contro l (ap): 4.4±0.7 [ lA/cm^; +TRAM-34: 1.5±0.2 piA/cm^; p < 0.05, n = 6) and 
basolateral side (Fig. 3.2.3.2B; Control (bl): 6.6土0.5 piA/cm^' +TRAM-34: 2.8±0.3 
piA/cm^; p < 0.05, n 二 5), respectively. In the presence o f Chromanol 293B, the 
cordycepin- induced Isc was reduced by 60.6% and 69.3% at apical (Fig. 3 .2.3. IC; 
Contro l (ap): 4.4土0.7 nA/cm^; +Chromanol 293B: 1.8±0.5 piA/cm^; p < 0.05, n = 5) and 
basolateral side (Fig. 3 .23.2C; Control (bl): 6.6±0.5 ^lA/cm^; +Chromanol 293B: 
2.0±0.3 ^lA/cm^; p < 0.05, n = 5), respectively. 
Exper iments were conducted to f ind ou t whe the r TRAM-34 and Chromanol 
293B wou ld have synergistic effects on inh ib i t ing cordycepin- induced Isc. 16HBE14o-
cells were pret reated w i th bo th blockers for at least 5 minutes before cordycepin 
s t imula t ion. The inhib i tory ef fect appeared to be larger w h e n these t w o blockers 
were added to 16HBE14o- epi thel ia tha t cordycepin- induced Isc response reduced by 
78.9% and 66.7% at apical (Fig. 3 .2 .3 . ID; Control (ap): 4.4±0.7 piA/cm^; +TRAM-34 
and Chromanol 293B: 0.9±0.3 piA/cm^; p < 0.05, n = 4) and basolateral side (Fig. 
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3.2.3.2D; Control (bl): 6.6±0.5 nA/cm^; +TRAM-34 and Chromanol 293B: 2.2±0.3 
HA/cm�；p < 0.05, n 二 4), respectively. However, the combined effect of t w o blockers 
was not signif icantly greater than thei r individual effect (p > 0.05, One-way ANOVA). 
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Fig. 3.2.3.1 - Representative recordings of Uc in response to apical application of 10 
piM cordycepin, in control epithelia (A) and in presence of 10 piM TRAM-34 (B) or 10 
HM Chromanol 293B (C), and both blockers added together (D). The blockers were 
applied for at least 5 minutes before the addi t ion of cordycepin. The dot ted line 
represents the zero current level. 
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Fig. 3.2.3.2 - Representative recordings of Isc in response to basolateral application 
of 10 nM cordycepin, in control epithelia (A) and in presence of 10 piM TRAM-34 (B) 
or 10 n M Chromanol 293B (C), and both blockers added together (D). The blockers 
were applied for at least 5 minutes before the addit ion of cordycepin. The dot ted line 
represents the zero current level. 
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Fig. 3.2.3.3 - Summarized data showing the inhibitory action of K+ channel blockers 
on cordycepin-induced I sc. Control was the apical or basolateral appl icat ion of 
cordycepin alone. Each co lumn represents the mean 土 S.E. ( *p < 0.05, * * p < 0.01, 
* * * p < 0.001, Student's t-test compared w i th control , n 二 4-9). However, there are no 
signif icant differences between single-blocker and two-blocker- t reated groups (p > 
0.05, One-way ANOVA). 
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3.2.4 Involvement of Adenylate Cyclase/cAMP/Protein Kinase A 
Pathway in Cordycepin-induced Isc Response 
The inhib i tory act ion of CFTR.inhi72 and Chromanol 293B on cordycepin- induced 
Isc showed tha t cAMP-depdendent ion channels (CFTR and KvLQTl) were involved In 
c r secretions across 16HBE14o- epithel ia. To investigate the involvement of 
AC/cAMP/PKA pathways in cordycepin- induced Uc, 16HBE14o- monolayers were 
loaded w i th MDL-12330A (1 _ or H89 (1 _ for 15 minutes before cordycepin 
st imulat ion to determine the change in Isc. 
Fig. 3.2.4.1 and 3.2.4.2 showed the typical tracings of Isc after the appl icat ion of 
10 piM cordycepin at e i ther side of 16HBE14o- epithel ia, w i t h or w i t hou t 
pre t reatment o f cAMP-dependent pathway inhibitors. For MDL-12330A, the basal Isc 
did not change when MDL-12330A was added to the apical side of the monolayer. 
The cordycepin- induced Uc was reduced by 71.9% and 46.7% at apical (Fig. 3.2.4. IB; 
Control (ap): 4.4±0.7 piA/cm^; +MDL-12330A: 1.3±0.4 piA/cm^; p < 0.05, n = 5) and 
basolateral side (Fig. 3.2.4.2B; Control (bl): 6.6±0.5 ^A/cm^; +MDL-12330A: 3.5±0.3 
HA/cm^; p < 0.05, n 二 5), respectively. 
For H89, the basal Isc did not change w h e n H89 was added to the apical side of 
the monolayer. The CM-induced Isc was reduced by 66.2% and 65.7% at apical (Fig. 
3.2.4.IC; Control (ap): 4.4±0.7 nA/cm^; +H89: 1.5±0.3 | iA/cm^; p < 0.05, n = 5) and 
basolateral sides (Fig. 3.2.4.2C; Control (bl): 6.6±0.5 piA/cm^; +H89: 2.3±0.3 ^A/cm^- p 
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Fig. 3.2.4.1 一 Representative recordings of Uc in response to apical application of 10 
piM cordycepin, in the absence (A) or presence of 1 nM MDL-12330A (B) or 1 jiM 
85 
H89 (C). The inhibitors were appl ied for 15 minutes before the addi t ion o f cordycepin. 
The do t ted line represents the zero current level. 
86 
A Ml B 





t T t 
Cordycepin (BL) MDL-12330A (AP) Cordycepin (BL) 






H89 (AP) Cordycepin (BL) 
( 1 _ {10 _ 
Fig. 3.2.4.2 - Representative recordings of Isc in response to basolateral application 
of 10 ^M cordycepin, in the absence (A) or presence of 1 ^M MDL-12330A (B) or 1 
HM H89 (C). The inhibitors were applied for 15 minutes before the addi t ion of 
cordycepin. The dot ted line represents the zero current level. 
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Fig. 3.2.4.3 - Summarized data showing the effect of MDL-12330A and H89 on Isc 
response to cordycepin. Control was the apical or basolateral appl icat ion o f 
cordycepin alone. Each co lumn represents the mean 土 S.E. ( *p < 0.05, * * p < 0.01, 
* * * p < 0.001, Student's t-test compared w i t h control , n 二 5-9). 
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3.2.5 Involvement of Ca^^-Dependent Pathway in 
Cordycepin-induced Isc Response 
In the previous part , the cordycepin- induced Isc was inhib i ted by DIDS and 
TRAM-34. This suggested tha t Ca^^-dependent channels (e.g. CaCC, KCNN4) wou ld be 
act ivated w h e n cordycepin was appl ied to 16HBE14o- cells. To study the invo lvement 
of the Ca^^-dependent pa thway in cordycepin- induced Uc response, Ca^^ ion chelator 
BAPTA-AM (50 piM) was appl ied t o 16HBE14o- cells for 45 minutes before 10 piM 
cordycepin s t imulat ion. 
Fig. 3.2.5.1 and Fig. 3.2.5.2 showed the typical tracings o f Isc af ter the 
appl icat ion o f 10 piM cordycepin at e i ther side o f 16HBE14o- epi thel ia, w i t h or 
w i t h o u t p re t rea tment o f BAPTA-AM. The basal Isc d id not change w h e n BAPTA-AM 
was added to the basolateral side o f the monolayer. The cordycepin- induced Uc was 
reduced by 55.0% and 46.7% at apical (Fig. 3 .2 .5. IB; Control (ap): 4.4±0.7 piA/cm^; 
+BAPTA-AM: 2.0±0.5 piA/cm^; p < 0.05, n = 5) and basolateral side (Fig. 3.2.5.2B; 
Contro l (bl): 6.6±0.5 nA/cm^; +BAPTA-AM: 3.5土0.5 piA/cm^; p < 0.05, n = 5), 
respectively. The summarized results were shown in Fig. 3.2.5.3. 
89 
A _ B 
IT 
2.5 [lA 
2.5 |iA ^ 
• i J I 5 min 
5 min 
f t f 
Cordycepin (AP) BAPTA-AM (AP) Cordycepin (AP) 
(10 _ (50 _ (10 _ 
Fig. 3.2.5.1 - Representative recordings of Uc in response to apical application of 10 
^M cordycepin, in the absence (A) or presence of 50 ^M BAPTA-AM (B). The 
inhibi tor was applied for 45 minutes before the addi t ion o f cordycepin. The do t ted 
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Fig. 3.2.5.2 - Representative recordings of Isc in response to basolateral application 
of 10 jiM cordycepin, in the absence (A) or presence of 50 nM BAPTA-AM (B). The 
inh ib i tor was appl ied for 45 minutes before the add i t ion o f cordycepin. The do t ted 
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Fig. 3.2.5.3 - Summarized data of the effect of the BAPTA-AM on 
cordycepin-induced Isc response. Contro l was the apical or basolateral appl icat ion o f 
cordycepin alone. Each co lumn represents the mean 土 S.E. ( *p < 0.05, *电*p < 0.001, 
Student 's t-test compared w i t h contro l , n = 5-9). 
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3.2.6 Effect of Cordycepin on Intracellular Ca^ ^ Concentrations 
In the previous exper iments, cordycepin- induced Uc could be inhibited by 
BAPTA-AM, suggesting that the Ca^''-dependent pathway was activated by cordycepin. 
An al ternat ive method was used to ascertain whe the r cordycepin activates this 
pathway by increasing [Ca^+L o f 16HBE14o- cells. In order to measure [Ca^^j, 
conf luent 16HBE14o- cells were loaded w i th Fura-2 A M f luorescent dye for 45 
minutes and observed under an inverted microscope. As cordycepin was a wh i te 
powder which gave a colourless solut ion when dissolved in water, it did not interfere 
w i t h the accurate measurement o f Fura-2 f luoresence ratio. The change in 
f lorescence ratio wou ld be detected by PTI f luorescence system. Higher f luorescence 
ratio represents higher [Ca^+L 
Fig. 3.2.6.1 showed the representative record of the change in Fura-2 
f luorescence ratio (340 n m / 380 nm) af ter apical s t imulat ion by 100 | iM cordycepin 
dissolved in normal K-H solut ion. Cordycepin could increase f luorescence ratio in a 
dose-dependent manner (Fig. 3.2.6.2), f r o m 0.025±0.051 (3 ^iM) to 0.408±0.092 (100 
[ iM) (n = 4-9). The EC50 of cordycepin for the increase in intracellular Ca^^ 
concentrat ion was 27.89 j iM . The cordycepin- induced Ca "^" response was a transient 
sharp peak appeared at few minutes after cordycepin appl icat ion and then slowly 
returned to basal level. 
Fig.3.2.6.3B showed a representative record of the change in Fura-2 
f luorescence ratio af ter apical st imulat ion by 100 piM cordycepin dissolved in 
nominal ly Ca^Vree K-H solut ion. Cordycepin could not produce a significant increase 
in f luorescence ratio (0.057±0.041, n = 8), which was 86.1% smaller than that in the 
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Fig. 3.2.6.1 - Representative record of Fura-2 fluorescence ratio (340 nm/ 380 nm) 
in response to 100 ^M cordycepin at the apical side of the 16HBE14o- monolayer. 
The f luorescence ratio was posit ively related to intracellular Ca "^^  concentrat ions. The 
apical side of the cells was perfused w i th normal K-H solut ion th roughou t the 
exper iment (n = 4- 9). 
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Fig. 3.2.6.2 - Dose-response curve of cordycepin in [Ca^^j of confluent 16HBE140-
epithelia. Changes in were p lot ted against the logar i thm o f cordycepin 
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Fig. 3.2.6.3 - Representative records of Fura-2 fluorescence ratio (340 nm/ 380 nm) 
in response to 100 \iM cordycepin in different buffered solutions (Normal K-H 
solution in A and Nominally Ca^Vree K-H solution in B) at the apical side of 
16HBE140- monolayer. The f luorescence ratio was positively related to [Ca^^j. The 
apical side of the cells was perfused w i th normal K-H solut ion init ial ly and then 
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Fig. 3.2.6.4 - Summarized data showing the change in Fura-2 fluorescence ratio 
induced by 100 ^M cordycepin in buffers with or without Ca^ ^ content. Control was 
normal K-H solut ion w i t h 2.56 m M Ca^^ content whi le nominal ly Ca "^" K-H solut ion 
was 0 m M Ca^^ content . Each column represents the mean 土 S.E. ( * * p < 0.01, 
Student 's t-test compared w i th control , n = 8-9). 
97 
3.2.7 Effect of Cordycepin on Apical CI" Current and Basolateral K+ 
Current in Nystatin-Permeabilized Epithelia 
Isc in intact epithel ia represents the net active ion t ranspor t across both apical 
and basolateral membranes. Nystatin permeabi l izat ion was useful to selectively 
study the individual effect of cordycepin on trans-epithel ial t ranspor t across apical 
membrane of 16HBE14o- cells. The basolateral side has been permeabil ized by 360 
pig/ml nystatin for at least 45 minutes. Af ter that , an asymmetr ical CI" gradient was 
set-up across the intact membrane before 30 [ iM cordycepin st imulat ion for 
determinat ion o f lci(ap). Addi t ion of Ci" channel blockers reduced the basal current by 
1.6±0.2 [xA/cm^ (10 ^ M CFTR.jnhm) and 61.1±5.4 | iA/cm^ (300 piM DIDS). Af ter the 
establ ishment of apical-to-basolateral CI" gradient and permeabi l izat ion o f 
basolateral membrane, pret reatment o f CFTR.jnhm or DIDS in permeabil ized epithel ia 
inhibi ted cordycepin- induced lci(ap) (Fig. 3 .2 .7 . lA) by 92.0% (Fig. 3.2.7. IB; Control (ap): 
~4.5±1.2 piA/cm^; +CFTR_inhi72: -0.4±0.4 piA/cm^; p < 0.05, n = 7) and 90.7% (Fig. 
3.2.7.IC; Control (ap): "A -S i l .〗 piA/cm^; +DIDS: -0.4±0.3 [xA/cm^; p < 0.05, n = 6), 
respectively. The lci(ap) induced by 2 | iM forskolin showed that the CFTR CI" channels 
in 16HBE140- monolayer could be fu r ther act ivated. The summarized results were 
shown in Fig. 3.2.7.2. 
In order t o study the effect of cordycepin on electrogenic ion t ranspor t across 
the basolateral membrane of 16HBE14o- monolayers, the apical side was 
permeabil ized by 360 pig/ml nystatin for at least 45 minutes. Af ter that , an 
asymmetr ical K+ gradient was set-up across the intact membrane before 30 piM 
cordycepin st imulat ion for determinat ion of 1啊.However , af ter the establ ishment of 
apical-to-basolateral K+ gradient and permeabi l izat ion of apical membrane, 30 | iM 
cordycepin could not st imulate a significant Increase in basolateral K+ current in 
permeabil ized epithel ia, which was only 1.3±0.7 | iA/cm^ (Fig. 3.2.7.3). The fur ther 
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basolateral K+ current induced by 300 | iM 1-EBIO showed tha t 16HBE14o- monolayer 
was under normal condit ions. 
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Fig. 3.2.7.1 - Representative trace records of apical CI" current lci(ap) after application 
of 30 nM cordycepin, in the absence (A) or presence of 10 jiM CFTR_inhi72 (B) or 300 
HM DIDS (C). The basolateral membrane has been permeabil ized by 360 pig/ml 
100 
nystatin for at least 45 minutes before addi t ion of cordycepin. The fu r ther addi t ion of 
2 | i M forskolin at the apical side af ter each exper iment was an indication of normal 
response in trans-epithel ial CI" t ransport . The dot ted line represents the zero current 
level. 
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Fig. 3.2.7_2 - Summarized data showing the effect of CI" channels blockers on apical 
cr conductance induced by cordycepin. Control was the apical appl icat ion of 
cordycepin alone. Each column represents the mean ± S.E. ( * * p < 0.01, Student's 
t-test compared w i th control, n = 5-7). 
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Fig. 3.2.7.3 - Representative trace record of basolateral K+ current iK(bi) after 
application of 30 nM cordycepin. Apical membrane has been permeabil ized by 360 
pig/ml nystatin for at least 45 minutes before addi t ion o f cordycepin. The fur ther 
addi t ion of 300 | iM 1-EBIO at the basolateral side after the exper iment was an 
indicat ion of normal response in trans-epithel ial K+ movement . The do t ted line 
represents the zero current level (n - 4). 
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3.2.8 Effect of Cordycepin on PKA Activity 
To fu r ther substantiate the act ivat ion o f AC/cAMP/PKA pathway by cordycepin, 
PepTag® non-radioact ive cAMP-dependent protein kinase assay kit was used to 
measure PKA activit ies in 16HBE14o- cells. The PepTag® assay kit contains highly 
coloured, f loresecent pept ide substi tutes tha t are highly specific for each PKA 
(PepTag® A l Peptide - LRRASLG). Conf luent cells were t reated w i th 10 [ iM cordycepin 
or 10 n M UDP (a known activator of PKA). Activated PKA phosphorylate highly the 
pept ide substrates and change the net charge of peptides f r o m +1 to -1. During 
electrophoresis, phosphorylated peptides moved towards the positive terminal . 
Fluorescence intensities represent Intracellular PKA activit ies of the cells. 
Fig. 3.2.8.1 showed the image of the 0.8% agarose gel of a typical PKA assay. In 
this photo, conf luent 16HBE14o- cells were t reated w i th ei ther vehicle alone (control, 
lane 1), cordycepin (5 minutes: lane 2, 15 minutes: lane 3); or UDP (10 minutes, lane 
4). The negative and positive controls provided by the PKA assay kit were shown in 
lane 5 and 6. The assay results (Fig. 3.2.8.2) suggested tha t cordycepin was able to 
signif icantly increase the intracellular PKA activi ty by 120.7% (5 minutes t reatment ) 





Fig. 3.2.8.1 - Image of the 0.8% agarose gel of a typical PKA assay after cordycepin 
stimulation. Descript ions for each lane: Lane 1 (Control, vehicle alone); Lane 2 (10 
^ilVI cordycepin, 5 minutes); Lane 3 (10 | i M cordycepin, 15 minutes); Lane 4 (100 | i M 
UDP, 10 minutes); Lane 5 (PKA assay kit negative control) ; Lane 6 (PKA assay kit 
posit ive control) . Af ter electrophesis, the synthetic pept ides in the react ion mix ture 
were separated into t w o groups: Non-phosphory la ted pept ides (Posit ively-charged) 
moved towards the negative termina l of power supply (The upper row); 
phosphory la ted peptides (Negatively-charged) moved towards the posit ive te rmina l 
of pwer supply (The lower row). 
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Fig. 3.2.8.2 - Summarized data showing the relative intracellular PKA activity 
stimulated by cordycepin. Control was the t reatment of vehicle (K-H Solution) alone. 
The intracellular PKA activities in treated cells were compared to that in the control 
cells, thus the relative PKA activity of the control cells would be counted as 1. Each 
column represents the mean 土 S.E. ( *p < 0.05, Student's t-test compared w i th control, 
n = 5). 
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Chapter 4 Discussion 
4.1 Regulation of Ion Transport in 16HBE14o- Cells by CM Extract 
Ion t ranspor t is an essential act ivi ty for human bronchial epithel ial cells. This is 
because the bronchial ep i the l ium is protected by a f i lm of ASL The ASL provides 
moisture to compensate the loss o f water dur ing breathing. At the same t ime, ASL is 
impor tan t in mucus clearance in tha t it can t rap foreign particles or pathogens 
enter ing the respiratory tract and then be removed by the beating mot ion o f cilia and 
microvil l i , wh ich is a kind of non-specific Immune protect ion. However, the vo lume 
and thickness of ASL should be t ight ly control led in order t o minimize the resistance 
to air f low. As ment ioned above, the ASL is made of mucous and aqueous layers. By 
regulat ion o f ion t ransport , the salt (e.g. Na+ and CI ) and water composi t ion in the 
ASL can be control led easily. 
From the above experiments, CM extract st imulated the increase in Uc at bo th 
apical and basolateral sides of the 16HBE14o- epithel ia in a dose-dependent manner, 
which gave sigmoid-shaped dose-response curves. The size of the Uc response in 
apical s t imulat ion was a bit larger than tha t in basolateral st imulat ion. It appeared 
tha t the Uc response at both sides of the cells was control led by similar intracellular 
signall ing mechanisms. It might be due to the CFTR CI. channels as wel l as 
intracellular signaling proteins being confined to the apical domain o f 16HBE14o-
cells (Wong et oL, 2009). Another possibil ity is that the permeable support (i.e. 
Transwell-COL fi l ters) of the cells might cause an obstruct ion for active ingredients of 
CM extract to reach the basolateral side. 
The increase in Isc by CM extract could be Inhibited by CI" channels blockers like 
CFTR.inhi72 (Taddei et al” 2004) and DIDS (Nelson et ai, 1997). The results show that 
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c r secretion was present w h e n 16HBE14o- cells were st imulated by CM extract, most 
probably th rough opening o f CFTR CI" channels and CaCC. CFTR CI" channels are 
cAMP-dependent , which could be activated by the addi t ion of forskolin, the act ivator 
o f adenylate cyclase (Seamon et al., 1981). On the other hand, CaCCs are 
Ca^^-de pen dent and therefore the addi t ion of DIDS could not block the 
CFTR-sensitive currents (Schwiebert et al., 1998). The CaCCs are common ly 
expressed in ai rway epithel ia cells, including 16HBE14o- (Barro Soria et al., 2009; 
Hartzell et al., 2005). Some o f t hem are activated by phosphorylat ion f rom 
calmodul in prote in kinase when is high (Wagner et al., 1991). The involvement 
o f CFTR channels and CaCC imply the act ivat ion of both Ca^""- and cAMP-dependent 
signal t ransduct ion pathways by the extract. Bumetanide is a Na+-K+-2C|-
co-transporter (e.g. NKCCl) inhib i tor that could reduce the CM-induced Uc response 
as wel l . Thus NKCCl is also involved in maintain ing electrical balance o f epithel ial 
cells th rough active t ranspor t o f ions (Hannert et al., 2002). 
On the o ther hand, the apical CM extract- induced Isc could be inhibi ted by K+ 
channel blockers, such as TRAM-34 and Chromanol 293B. This suggests tha t K+ 
movement was involved in the Isc response. K+ channels are more commonly found in 
the basolateral membrane of epithel ial cells (Kunzelmann et al., 2005) to provide a 
dr iv ing force for apical CI" secretions. Chromanol 293B is a cAMP-activated K+ channel 
KvLQTl blocker (Loussouarn et ai, 1997). Since KvLQTl could be expressed in the 
basolateral side of 16HBE14o- cells (Bernard et al., 2003; Mal l et al., 2000; Moser et 
al., 2008), the inhib i t ion o f apical CM-induced response by Chromanol 293B implies 
the act ivat ion of cAMP-dependent pathway in K+ movement t o maintain a large 
dr iv ing force for apical C「exit (Warth et al., 1996). At the same t ime, TRAM-34 is an 
intermediate-conductance Ca^"'-activated K+ channel KCNN4 blocker (Reich et al., 
2005). As there is intermediate-conductance Ca^^-activated K+ channels expressed in 
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16HBE140- cells (Bardou et al., 2008; Bernard et al., 2003; Kunzelmann et al., 2005), 
the data suggest the involvement o f these K+ channels in CM-induced response. 
KCNN4 channels are also located at the basolateral side o f the epithel ia to provide 
dr iv ing force for eff ic ient apical eff lux o f anions (Smith et al., 1984; War th , 2003). 
However, both K+ channel blockers could not suppress the CM-induced response at 
the basolateral side, suggesting tha t the K+ channels were not activated w h e n CM 
extract was added to the basolateral side of the cells. 
In the case of nystat in-permeabi l ized epithel ia, the inhibi tory pat tern o f CI" 
blockers was similar to tha t observed in the intact epi thel ia. Data show tha t the 
apical c r current wou ld be smaller w h e n the monolayer was pretreated w i th 
CFTR.jnhi72 or DIDS. Thus, addi t ion o f CM extract in the apical side could increase the 
apical c r conductance significantly. Alternatively, exper imental data show that 
basolateral K+ current was inhibi ted by TRAM-34 or Chromanol 293B. The results 
suggest tha t basolateral K+ channels were activated In nystat in-permeabil ized 
epithel ia for ion absorpt ion. On the o ther hand, they became less active in intact 
epithel ia because litt le K+ movement was required to faci l i tate eff ic ient CI" t ranspor t 
th rough the apical membrane. The coupl ing of apical and basolateral membranes is 
essential t o control basolateral K+ conductance for ion secretion and absorpt ion 
(Dawson et al., 1990). 
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4.2 Intracellular Signaling Mechanisms behind CM-induced Uc 
Responses 
The act ivat ion of cAMP- and Ca^^-dependent CI" and K+ channels by CM extract 
suggest the involvement of cAMP- and Ca^^-dependent signaling pathways. In order 
to investigate whe the r these pathways were activated dur ing CM-induced response, 
d i f ferent intracellular signaling inhibitors were added to 16HBE14o- epithel ia for 
measuring the changes in Isc. For cAMP-dependent pathway, MDL-12330A and H89 
were used to inhibi t the activit ies o f adenylate cyclase (AC) and protein kinase A 
(PKA), respectively. The data show that CM-induced Isc responses were smaller when 
MDL-12330A was added to reduce fo rmat ion o f cAMP f r om AC (Gadea et al., 1999). 
Similarly, the inhibi t ion o f PKA by H89 could make the CM-induced response much 
lower than tha t in control (Chijiwa et al., 1990). Also, f r om the data in PKA assay, the 
PKA activi ty of CM-treated cells was higher than that of the untreated cells. These 
f indings suggested that CM extract could st imulate the AC/cAMP/PKA pathway for 
opening of cAMP-dependent channels (e.g. CFTR channels) for CI" secretions as wel l 
as cAMP-depedent K+ channels (e.g. KvLQTl) for generat ion o f basolateral dr iv ing 
force. The PKA activit ies o f CM-treated cells were more or less the same w h e n the 
t rea tment period was 5 minutes and 15 minutes. The data supported tha t the act ion 
of CM extract was so fast that the intracellular PKA activity reached the max imum 
level in a very short period of t ime. 
For the Ca^'^-dependent pathway, BAPTA-AM was used to chelate intracellular 
Ca2+ to prevent fur ther Increase in [Ca^^j (Tang et al., 2007). The data indicate tha t 
the CM-induced response wou ld be inhibited by the appl icat ion of BAPTA-AM, 
implying that the Ca^^-de pen dent pathway was st imulated for opening of 
Ca2+-activated channels like CaCC and KCNN4. 
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4.3 Regulation of Ion Transport in 16HBE14o- Cells by Cordycepin 
As cordycepin was present in a significant amount (0.2480% by weight ; Yue et al., 
2008) in the CM extract, we wou ld like to know if this compound was responsible for 
t r igger ing CM-induced st imulat ion in Isc. Similar to the previous part, addi t ion of 
cordycepin could increase the Isc at both apical and basolateral sides in a 
dose-dependent manner. The dose-response curves are sigmoid in shape. The size of 
Isc response in basolateral s t imulat ion was a bit larger than tha t in apical s t imulat ion. 
According to the previous research, 100 pig/ml of CM extract contained about 1 
l-iM of cordycepin (Yue et al., 2008). From the combined dose response curves o f CM 
extract and cordycepin (Fig. 4.3.1), the Isc response induced by 1 pilVI cordycepin only 
accounts for about 2-4% of tha t induced by 100 | i g /m l CM extract (100 pig/ml CM 
Extract (ap): 22.92±2.83 [xA/cm^; 1 [ iM Cordycepin (ap): 0.63±0.36 piA/cm^; 100 
i^g/ml CM Extract (bl): 14.31±1.73 nA/cm ;^ 1 l^M Cordycepin (bl): 0.63±0.36 [xA/cm ;^ 
p < 0.05, n = 4-11). Thus, cordycepin might not be a major compound for ini t iat ing 
CM-induced Uc response. The actual Uc response might be induced by a group of 
nucleosides inside the CM extract (Yuan et al., 2008; Yue et al., 2008). 
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Fig. 4.3.1 - Dose-response curves of CM extract (Apical: •； Basolateral: • ) and 
cordycepin (Apical: T； Basolateral: A ) in Isc changes in confluent 16HBE14o-
epithelia. The concentrat ions of cordycepin were expressed in terms of equivalent 
CM extract concentrat ions (i.e. 100 pig/ml of CM extract contained 1 \xM cordycepin, 
according to HPLC results in Yue et al., 2008). Changes In Uc were plot ted against the 
logar i thm of concentrat ion used (n = 4-11). 
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For the involvement o f CI" t ranspor t , it was found tha t the cordycepin- induced Isc 
response at both sides could be inhibi ted by CFTR-inhi72 or DIDS. Thus, cordycepin 
could also st imulate CI—secretion f rom 16HBE14o- cells, like the CM extract. 
For the involvement of K+ t ransport , data show that TRAM-34 or Chromanol 
293B could block the increase in cordycepin- induced Isc response at both sides. This 
suggested tha t basolateral K+ channels were activated when cordycepin was applied 
to epithel ia. 
In nystatin-permeabil ized epithel ia, 30 [ iM cordycepin was able to init iate apical 
c r current that could be inhibi ted by CFTR—inhm and DIDS. Thus, cordycepin could 
increase C「conductance for apical secretions. However, high concentrat ion of 
cordycepin could only st imulate a m in imum basolateral K+ current when apical side 
was permeabil ized by nystatin. This revealed that cordycepin had l imited st imulatory 
effect on basolateral K+ conductance in 16HBE14o- cells. 
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4.4 Intracellular Signaling Mechanisms behind Cordycepin-induced Isc 
Responses 
Similar t o CM extract, cordycepin was able to tr igger Isc responses th rough 
act ivat ion of cAMP- and Ca^'^-dependent channels. Thus, we wou ld like to use 
d i f ferent techniques were used to investigate whether cordycepin could activate 
AC/cAMP/PKA and Ca^""-dependent pathways as wel l . 
Pretreatment of MDL-12330A, H89 as wel l as BAPTA-AM could reduce 
cordycepin- induced Uc- The results imply tha t both Ca^^ and cAMP-dependent 
pathways are involved, wh ich is similar to tha t observed in CM extract. The 
cordycepin- induced [Ca^^j increase was measured by Fura-2 f luorescence technique. 
In general, cordycepin was able to increase Ca?. concentrat ions inside the 16HBE14o-
cells in a dose-dependent manner, which is consistent w i t h data using BAPTA-AM. 
However, the increase in Ca^^ concentrat ion was very small tha t it could only be 
observed at a high dosage of cordycepin (e.g. 30-100 piM). In addi t ion, the 
cordycepin- induced Ca^^ increase was abolished in Ca^Vree buffer. This il lustrates 
tha t cordycepin did not increase Ca "^" concentrat ion by mobil iz ing Ca^^ f r om internal 
storage (e.g. endoplasmic ret iculum) (Lytton et al., 1991). Further exper iments were 
needed to conf i rm the actual mechanism of Ca "^^  Increase induced by cordycepin. 
PKA assay was used to est imate the st imulat ion of PKA activi ty by cordycepin in 
d i f ferent t ime course. Data showed tha t cordycepin-treated cells at 10 piM wou ld 
have 2-folcl higher PKA activities than untreated control cells. PKA activit ies wou ld be 
1.2 t imes higher when cordycepin st imulat ion increased f rom 5 minutes to 15 
minutes. These results suggested that cordycepin could effectively st imulate 
AC/cAMP/PKA pathway, but 3 t imes slower than CM extract to reach the max imum 
PKA activit ies. 
A l though there is no direct evidence to show the involvement of receptors in 
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this project, it is believed tha t active ingredients, including cordycepin, may bind to 
adenosine receptors for int iat ions o f Isc responses. 
Adenosine receptor is a group o f membrane proteins tha t are specific to the 
binding of adenosine and other related molecules (e.g. cordycepin). There are four 
d i f ferent subtypes expressed in human body. They are A l , A2a, A2b and A3 receptors. 
The expressions of these four subtypes are d i f ferent . In some research results, it is 
found that the receptors may organize to f o rm "microdomains" in the lipid rafts to 
increase the eff iciency of t raf f icking across the cell membrane (Lasley, 2011). In many 
airway epithel ial cell lines, such as Calu-3, CFBE41o- and pr imary cul ture human 
airway cells, the expression o f A2b substype is much higher than o ther three 
substypes (Li et al., 2006). 
A2b receptor is a kind of G-protein coupled receptor (GPCR). The structure o f 
A2b receptors consists of seven t rans-membrane domains. The amino acid sequence 
of A2b is about 45% identical to tha t of A2a receptors (Feoktistov et al., 1996). 
Besides airway epithel ial cells, A2b receptors are also expressed in smooth muscle 
cells, neurons, macrophages and f ibroblasts. The receptor exhibits various funct ions 
in d i f ferent cell lines (Hasko at el” 2009). For example, in airway epithel ial cells, it 
plays an impor tant role in regulation o f ASL height so as to maintain physical barrier 
funct ions against foreign pathogens (Com et al., 2009). Also, in the immune system, 
A2b receptors can tr igger the release of cytokines and o ther pro- in f lammatory 
proteins f r om mast cells and marcophages for Initat ion of specific immune responses 
(Zhou et al., 2009). 
When A2b receptors are activated, this wi l l couple to di f ferent signal 
t ransduct ion pathways. The activated receptor can recruit Gs-alpha subunit to 
st imulate adenylate cyclase to produce cAMP, the increased intracellular cAMP 
concentrat ion leads to the activation of cAMP-dependent ion channels (e.g. CFTR 
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channels and CaCCs) (Hasko at el., 2009). 
On the o ther hand, the activated A2b receptor can also recruit Gq-alpha subunit , 
which can fu r ther st imulate phospholipase C (PLC) to increase the concentrat ions of 
diacyl glycerol (DAG) and inositol 1,4,5-tr isphosphate (IP3) in the cytosol. The actions 
of increased IP3 and DAG are activation o f Protein Kinase C (PKC) and increase in 
intracellular Ca "^" concentrat ion. Thus, Ca^''-dependent ion channels are activated, 
such as Ca2+-activated CI" channels and Ca^^-activated K+ channels. (Feoktistov et al., 
1996). 
Due to the abil i ty o f act ivating mult ip le intracellular pathways and high levels o f 
expression in human airway epithel ial cells, A2b receptors wou ld be a possible 
candidate tha t is responsible for CM-induced responses. 
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Chapter 5 Conclusion 
5.1 Summary 
In conclusion, both CM extract and cordycepin were able to st imulate Uc 
responses in conf luent 16HBE14o- epithel ia in a dose-dependent relat ionship. 
However, cordycepin might be one o f the active ingredients, but not the only active 
ingredient to evoke Uc responses in CM extract, a l though both CM extract and 
cordycepin had very similar effects on Uc responses and activation o f signal 
t ransduct ion pathways. The Uc responses evoked by CM extract and cordycepin could 
be blocked by CI" channel blockers CFTR.jnhm and DIDS, showing tha t the 
involvement o f CFTR channels and CaCC for apical CI secretion. Also, their responses 
were inhibi ted by K+ channel blockers, suggesting tha t basolateral K+ channels 
(KCNN4, KvLQTl) were involved to provide the dr iv ing force for CI" secretion. The 
inhibi t ion of PKA and AC by H89 and MDL-12330A in CM- and cordycepin-induced 
responses revealed the act ivat ion of AC/cAMP/PKA pathways. This could be fur ther 
conf i rmed by the Increase in intracellular PKA activit ies when 16HBE14o- cells were 
t reated w i th CM and cordycepin in PKA assay. Finally, the inhibi t ing effect of 
BAPTA-AM il lustrated the st imulat ion of the Ca^^-dependent pathway. This could be 
fu r ther supported w i th the increase in [Ca^+L measured by Fura-2 f luorescence ratio 
when cordycepin was applied to 16HBE14o- epithel ia. Al though cordycepin did not 
show a large effect on st imulat ing trans-epithel ial ion t ransport , it could elicit o ther 
biological activit ies through activation of intracellular signaling pathways. For 
example, cordycepin could increase [Ca^+L to tr igger apoptosis in human thyroid 
cancer cells (Chen et al., 2010) and eryptosis in mouse erythrocytes (Lui et al., 2007), 
as wel l as activate AC/cAMP/PKA pathway to promote steroidogensis in mouse 
117 
Leydig cells (Leu et al., 2011). 
Fig. 5.1.1 shows the proposed model for regulat ion of ion t ranspor t by CM 
extract and cordycepin in 16HBE14o- epithel ia. Active ingredients in CM extract 
( including cordycepin) activate both AC/cAMP/PKA and Ca^^-de pen dent pathways. It 
is thought tha t the ingredients interact w i t h the 16HBE14o- cells th rough adenosine 
receptors, especially the A2b substype (marked as quest ion mark). This wi l l lead to C「 
secretion th rough CFTR channels and CaCC at the apical side. Act ivat ion of 
basolateral cAMP- (e.g. KvLQTl) and Ca^"^-actlvated K+ channels (e.g. KCNN4) provide 
the dr iv ing force. Apart f r om opening ion channels, Na+-K+-2C「co-transporter (e.g. 
NKCCl) may play a role In maintaining electrical balance by active t ranspor t of ions. 
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Fig. 5.1.1 - Proposed model for regulation of ion transport by CM extract and 
cordycepin in human bronchial epithelia, 16HBE14o-. In this diagram, posit ive sign 
"+〃 represents s t imulat ion. 
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5.2 Future Directions 
Taken together f rom the data presented here and our previous study (Yue et al., 
2008), CM extract and cordycepin st imulates anion secretion f rom both surface 
epithel ia of the airways (16HBE14o- cells) and submucosal glands (Calu-3 cells). 
Enhancing f lu id and electrolyte t ranspor t may improve both airway surface hydrat ion 
and mucus clearance, which becomes hypersecreted in various respiratory diseases, 
such as asthma and COPD. Therefore, this s t imulatory effect of CM extract and 
cordycepin on major secretory cell types of the upper airways may account for its 
t radi t ional use in t reat ing d i f ferent respiratory diseases. Further study is required to 
del ineate the possible receptor(s) involved and the molecular mechanisms 
under ly ing the st imulatory effects of CM extract and cordycepin on ion t ranspor t In 
both normal and diseased airway epithel ia. Further exper iments are needed to pur i fy 
and characterize the other active component(s) present in the CM extract and 
determine the mechanisms of act ion for thei r therapeut ic effects since the 
prosecretory act ion of CM extract is not solely explained by the presence o f 
cordycepin. Calu-3 and 16HBE14o- cells are models for submucosal glands and 
airway surface epi thel ium, respectively. The airway consists o f d i f ferent cell types, 
such as goblet (mucous) cells, which secrete mucins. Goblet cell hyperplasia or 
metaplasia is commonly seen in airway diseases, such as asthma, COPD, and chronic 
bronchit is (Rogers, 2007). It is impor tan t t o examine whether CM extract or 
cordycepin has any effect on mucus secretion by goblet cells. Finally, more carefully 
conducted clinical trials should be per formed to evaluate the therapeut ic potent ial of 
CM extract and Its major ingredients in the t rea tment o f respiratory diseases. 
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